{
  "entity_id": "B-001937",
  "folder": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
  "name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
  "type": "Statutory Body",
  "jurisdiction": "Commonwealth",
  "portfolio": "Health, Disability and Ageing",
  "website": "https://www.nhmrc.gov.au/about-us/leadership-and-governance/committees/embryo-research-licensing-committee",
  "data_status": "rich",
  "completeness": {
    "has_strategy_brief": true,
    "has_strategy_structured": true,
    "has_vision": false,
    "has_kpi_targets": true,
    "has_kpi_results": true,
    "has_strategy_overview": true,
    "has_legislation_text": true,
    "has_legislation_structured": false,
    "has_global_initiatives_text": false,
    "has_ideas": true,
    "has_artifacts": true,
    "n_ideas": 12,
    "n_legislation": 0,
    "n_artifacts": 16,
    "n_kpi_targets": 4,
    "n_kpi_results": 4,
    "n_outcomes": 1,
    "verified_own_data": true
  },
  "strategy_profile": {
    "status": "published",
    "confidence": "high",
    "summary": "• fund high quality health and medical research and build research capability\n• support the translation of health and medical research into better health outcomes\n• promote the highest ethical standards in health and medical research",
    "official_site_url": "https://www.nhmrc.gov.au/about-us/leadership-and-governance/committees/embryo-research-licensing-committee",
    "source_documents": [
      {
        "type": "annual_report",
        "title": "2016–17",
        "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf",
        "period": "2016-17",
        "confidence": "high"
      },
      {
        "type": "annual_report",
        "title": "2015–16",
        "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf",
        "period": "2015-16",
        "confidence": "high"
      },
      {
        "type": "annual_report",
        "title": "2014–15",
        "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf",
        "period": "2014-15",
        "confidence": "high"
      },
      {
        "type": "annual_report",
        "title": "2013–14",
        "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/baa4d524-2b51-4ae9-8ae2-8667b250661d/upload_pdf/nh166_nhmrc_annual_report_2013_2014_accessible.pdf",
        "period": "2013-14",
        "confidence": "high"
      },
      {
        "type": "corporate_plan",
        "title": "NHMRC Corporate Plan 2025–26",
        "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
        "period": "2025-26",
        "confidence": "high"
      },
      {
        "type": "corporate_plan",
        "title": "NHMRC Corporate Plan 2024–25",
        "url": "https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf",
        "period": "2024-25",
        "confidence": "high"
      },
      {
        "type": "corporate_plan",
        "title": "2018–19",
        "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf",
        "period": "2018-19",
        "confidence": "high"
      },
      {
        "type": "corporate_plan",
        "title": "2017–18",
        "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/4ba2e828-a6a9-4c84-beab-a45c39967b6e/upload_pdf/17293_nhmrc_corporate_plan_2017-18-web.pdf;fileType=application%2Fpdf",
        "period": "2017-18",
        "confidence": "high"
      },
      {
        "type": "corporate_plan",
        "title": "2016–17",
        "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/2d6f9cb6-500b-4651-a2ad-d7785ebffe53/upload_pdf/16390_nhmrc_-_nhmrc_corporate_plan_2016-17_0.pdf;fileType=application%2Fpdf",
        "period": "2016-17",
        "confidence": "high"
      },
      {
        "type": "strategie",
        "title": "International Engagement Strategy 2023–2026",
        "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf",
        "period": "2023",
        "confidence": "medium"
      },
      {
        "type": "strategie",
        "title": "NHMRC Gender Equity Strategy",
        "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/NHMRC_Gender_Equity_Strategy_FA.pdf",
        "period": null,
        "confidence": "medium"
      },
      {
        "type": "strategie",
        "title": "National Framework for Consumer Involvement in Cancer Control | Cancer Australia",
        "url": "https://www.canceraustralia.gov.au/sites/default/files/migrated-files/publications/national_consumer_framework_web_504af020f2184.pdf",
        "period": null,
        "confidence": "medium"
      }
    ],
    "purpose": {
      "text": "• fund high quality health and medical research and build research capability\n• support the translation of health and medical research into better health outcomes\n• promote the highest ethical standards in health and medical research",
      "source_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
      "source_page": [
        11
      ],
      "source_deep_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf#page=[11]"
    },
    "vision": null,
    "strategic_priorities": [],
    "values": [
      {
        "name": "Investment",
        "description": "",
        "source_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
        "source_page": null
      },
      {
        "name": "Translation",
        "description": "",
        "source_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
        "source_page": null
      },
      {
        "name": "Integrity",
        "description": "",
        "source_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
        "source_page": null
      }
    ],
    "outcomes": [
      {
        "name": "Outcome 1: Improved health and medical knowledge",
        "description": "NHMRC’s purposes are implemented through a strategy with three underpinning key themes: investment, translation and integrity. The corporate plan sets out the key activities and performance measures, along with specific targets for 2016–17, within each of these themes.",
        "activities": [
          "funding research",
          "translating research findings into evidence-based clinical practice",
          "administering legislation governing research",
          "issuing guidelines and advice for ethics in health and the promotion of public health"
        ],
        "source_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
        "source_page": [
          6
        ],
        "source_deep_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf#page=[6]"
      }
    ],
    "performance_measures": [
      {
        "code": "CCE01",
        "measure": "Research grants are awarded, based on expert peer review, across the full spectrum of health and medical research areas.",
        "target": "Output",
        "latest_result": "Achieved",
        "status": "Achieved",
        "target_source_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
        "target_source_page": [
          46
        ],
        "result_source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf",
        "result_source_page": [
          31
        ]
      },
      {
        "code": "CCE02",
        "measure": "More than 5% of NHMRC’s annual budget is awarded to research that aims to improve health outcomes for Aboriginal and Torres Strait Islander people.",
        "target": "Output",
        "latest_result": "Achieved",
        "status": "Achieved",
        "target_source_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
        "target_source_page": [
          47
        ],
        "result_source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf",
        "result_source_page": [
          31
        ]
      },
      {
        "code": "CCE03",
        "measure": "Research integrity matters are managed appropriately by Administering Institutions in line with the requirements of the Australian Code for the Responsible Conduct of Research.",
        "target": "Effectiveness",
        "latest_result": "Work ongoing",
        "status": "Work ongoing",
        "target_source_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
        "target_source_page": [
          49
        ],
        "result_source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf",
        "result_source_page": [
          35
        ]
      },
      {
        "code": "CCE04",
        "measure": "Compliance with regulatory requirements under the Research Involving Human Embryos Act 2002.",
        "target": "Effectiveness",
        "latest_result": "Work ongoing",
        "status": "Work ongoing",
        "target_source_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
        "target_source_page": [
          49
        ],
        "result_source_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf",
        "result_source_page": [
          35
        ]
      }
    ],
    "document_alignment_terms": {
      "must_support": [
        "• fund high quality health and medical research and build research capability\n• support the translation of health and medical research into better health outcomes\n• promote the hig"
      ],
      "watch_terms": [
        "Research grants are awarded, based on expert peer review, across the full spectrum of health and medical research areas.",
        "More than 5% of NHMRC’s annual budget is awarded to research that aims to improve health outcomes for Aboriginal and Torres Strait Islander people.",
        "Research integrity matters are managed appropriately by Administering Institutions in line with the requirements of the Australian Code for the Responsible Conduct of Research.",
        "Compliance with regulatory requirements under the Research Involving Human Embryos Act 2002."
      ],
      "avoid_claiming_without_evidence": []
    },
    "review_note": ""
  },
  "strategy_brief_md": "# National Health and Medical Research Council - Embryo Research and Licensing Committee — Strategy Brief\n\n**Reporting period**: 2016-17\n**Corporate plan in force**: 2025-26\n**Annual Report**: [2016-17](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf)\n**Corporate Plan**: [2025-26](https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)\n\n## Our purpose / purposes\n\n> • fund high quality health and medical research and build research capability\n• support the translation of health and medical research into better health outcomes\n• promote the highest ethical standards in health and medical research [[CP p.[11]](https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf#page=[11])]\n\n## How we deliver\n\n> NHMRC’s purposes are implemented through a strategy with three underpinning key themes: investment, translation and integrity. The corporate plan sets out the key activities and performance measures, along with specific targets for 2016–17, within each of these themes. These activities align with those identified in NHMRC’s Portfolio Budget Statements 2016–17 [CP p.11](https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf#page=11)\n\n## Outcomes\n\n### Outcome 1: Improved health and medical knowledge\nNHMRC’s purposes are implemented through a strategy with three underpinning key themes: investment, translation and integrity. The corporate plan sets out the key activities and performance measures, along with specific targets for 2016–17, within each of these themes. [[CP p.[6]](https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf#page=[6])]\n\n**Key activities:**\n- funding research\n- translating research findings into evidence-based clinical practice\n- administering legislation governing research\n- issuing guidelines and advice for ethics in health and the promotion of public health\n\n## Values and principles\n\n_NHMRC’s strategy for health and medical research_\n\n- Investment\n- Translation\n- Integrity\n\n## What they will measure themselves on this year (targets from 2025-26 corporate plan)\n\n| Code | Measure | Target | Source |\n|---|---|---|---|\n| CCE01 | Research grants are awarded, based on expert peer review, across the full spectrum of health and medical research areas. | Output | [CP p.[46]](https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf#page=[46]) |\n| CCE02 | More than 5% of NHMRC’s annual budget is awarded to research that aims to improve health outcomes for Aboriginal and Torres Strait Islander people. | Output | [CP p.[47]](https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf#page=[47]) |\n| CCE03 | Research integrity matters are managed appropriately by Administering Institutions in line with the requirements of the Australian Code for the Responsible Conduct of Research. | Effectiveness | [CP p.[49]](https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf#page=[49]) |\n| CCE04 | Compliance with regulatory requirements under the Research Involving Human Embryos Act 2002. | Effectiveness | [CP p.[49]](https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf#page=[49]) |\n\n## How they performed last year (results from 2016-17 annual report)\n\n| Code | Measure | Result | Status | Source |\n|---|---|---|---|---|\n| CCE01 | Research grants are awarded, based on expert peer review, across the full spectrum of health and medical research areas. | Achieved | Achieved | [AR p.[31]](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf#page=[31]) |\n| CCE02 | More than 5% of NHMRC’s annual budget is awarded to research that aims to improve health outcomes for Aboriginal and Torres Strait Islander people. | Achieved | Achieved | [AR p.[31]](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf#page=[31]) |\n| CCE03 | Research integrity matters are managed appropriately by Administering Institutions in line with the requirements of the Australian Code for the Responsible Conduct of Research. | Work ongoing | Work ongoing | [AR p.[35]](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf#page=[35]) |\n| CCE04 | Compliance with regulatory requirements under the Research Involving Human Embryos Act 2002. | Work ongoing | Work ongoing | [AR p.[35]](https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf#page=[35]) |",
  "strategy_overview_evidence_md": null,
  "internal_strategy_evidence_md": "# National Health and Medical Research Council - Embryo Research and Licensing Committee - Strategy, Performance, and Operating Profile\n\n**Generated at**: 2026-05-09T22:21:51.091520+00:00\n**Entity ID**: B-001937\n**Entity type**: Statutory Body\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n**Website**: https://www.nhmrc.gov.au/about-us/leadership-and-governance/committees/embryo-research-licensing-committee\n\n> Draft generated from scraped source material. Treat this as an evidence pack for editorial review, not a final judgement.\n\n## Source Coverage\n\n| Source type | Count |\n|---|---:|\n| annual-reports | 4 |\n| corporate-plans | 5 |\n| other-pdfs | 3 |\n| pages | 42 |\n| reviews | 1 |\n| strategies | 3 |\n\n## Executive Readout\n\n### Purpose\n\n- Figure 2 NHMRC purposes mapped against PBS program objectives[1]\nNHMRC PURPOSE PBS PROGRAM OBJECTIVE\nSupporting high quality health and medical research\nFund high quality\nhealth and medical Boosting dementia research\nresearch and build\nresearch capability Streamlining grant assessment and management processes and\ndeveloping a nationally consistent approach to clinical trials\nSupport the Supporting the translation of health and medical research\ntranslation of health\nand medical\nresearch into better Streamlining grant assessment and management processes and\nhealth outcomes developing a nationally consistent approach to clinical trials\nPromoting the highest ethical standards in health\nPromote the highest\nand medical research\nethical standards in\nhealth and medical\nStreamlining grant assessment and management processes and\nresearch\n  Source: `corporate-plans/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/2d6f9cb6-500b-4651-a2ad-d7785ebffe53/upload_pdf/16390_nhmrc_-_nhmrc_corporate_plan_2016-17_0.pdf;fileType=application%2Fpdf)`\n- Figure 4 NHMRC purposes mapped to portfolio program objectives\nNHMRC PURPOSE PORTFOLIO OBJECTIVES\nSupporting high quality health and medical research\nFund high quality\nhealth and medical Boosting dementia research\nresearch and build\nresearch capability\nStreamlining grant assessment and management processes and\ndeveloping a nationally consistent approach to clinical trials\nSupporting the translation of health and medical research\nSupport the\ntranslation of health\nand medical\nStreamlining grant assessment and management processes and\nresearch into better\ndeveloping a nationally consistent approach to clinical trials\nhealth outcomes\nPromoting the highest ethical standards in health and medical research\nPromote the highest\nethical standards\nin health and\nStreamlining grant assessment and management processes and\nmedical research\ndeveloping a nationally consistent approach to clinical trials\n  Source: `annual-reports/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf)`\n- Annual Report of the National Health and Medical Research Council 2016–2017 89\ntnemnorivne\ngnitarepo\n3\nTRAP\nRisk management\nIn support of its mission and strategic objectives, NHMRC is committed to managing its risks both\nstrategically and systematically.\n  Source: `annual-reports/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf)`\n- Table 1 Investigator Initiated and Priority Driven NHMRC Funding\nOutcomes in 20157\nMAIN 2015\nFUNDING GRANT TYPE[a] GRANT SUB-TYPE\nINVESTIGATOR PRIORITY\nGROUP\nNew Investigator Grant $14,996,978\nStandard Project Grant $383,431,356\nProject Grants\nAboriginal and Torres Strait Islander\n$21,246,639\nHealth Research\nProgram Grants Program Grant $108,742,325\nCentre of Research Excellence\n$12,149,997\n– Clinical\nCentres of Research Centre of Research Excellence\n$12,198,638\nExcellence – Health Services\nCentre of Research Excellence\n$12,478,085\n– Population Health\nDevelopment Grants Development Grant $14,142,312\nPartnership Projects Partnership Project for Better Health $18,436,290\nAust/EU Collaborative Research\n$5,495,919\nGrant\nCalifornia Institute for Regenerative\nResearch Medicine (CIRM) – Tools and $1,784,170\nSupport Technologies Stem Cells Research\nInternational\n  Source: `corporate-plans/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/2d6f9cb6-500b-4651-a2ad-d7785ebffe53/upload_pdf/16390_nhmrc_-_nhmrc_corporate_plan_2016-17_0.pdf;fileType=application%2Fpdf)`\n\n### Role and Functions\n\n- ANNUAL REPORT REQUIREMENTS\nRef1 Part of Report Description Requirement Location\n8(3) & Letter of transmittal Mandatory i\nA.4\nA.5 Table of contents Mandatory ii\nA.5 Index Mandatory 196\nA.5 Glossary Mandatory 189\nA.5 Contact officer(s) Mandatory Inside\ncover\nA.5 Internet home page address and Internet address for report Mandatory Inside\ncover\n9 Review by Secretary\n9(1) Review by departmental secretary Mandatory 2\n9(2) Summary of significant issues and developments Suggested 2\n9(2) Overview of department’s performance and financial results Suggested 30\n9(2) Outlook for following year Suggested 2\n9(3) Significant issues and developments – portfolio Portfolio N/A\ndepartments\n– suggested\n10 Departmental Overview\n10(1) Role and functions Mandatory 8\n10(1) Organisational structure Mandatory 9\n10(1) Outcome and programme structure Mandatory 30\n  Source: `annual-reports/2013-14.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/baa4d524-2b51-4ae9-8ae2-8667b250661d/upload_pdf/nh166_nhmrc_annual_report_2013_2014_accessible.pdf)`\n- PART 5 APPENDIXES\nANNUAL REPORT REQUIREMENTS\nRef1 Part of Report Description Requirement Location\n8(3) & Letter of transmittal Mandatory i\nA.4\nA.5 Table of contents Mandatory ii-iii\nA.5 Index Mandatory 183-186\nA.5 Glossary Mandatory 177\nA.5 Contact officer(s) Mandatory inside\ncover\nA.5 Internet home page address and Internet address for report Mandatory inside\ncover\n9 Review by Secretary\n9(1) Review by departmental secretary Mandatory 2-4\n9(2) Summary of significant issues and developments Suggested 2-7\n9(2) Overview of department’s performance and financial results Suggested 2-7, 21-23\n9(2) Outlook for following year Suggested 2-7\n9(3) Significant issues and developments – portfolio Portfolio N/A\ndepartments\n– suggested\n10 Departmental Overview\n10(1) Role and functions Mandatory 8-11\n10(1) Organisational structure Mandatory 9\n10(1) Outcome and programme structure Mandatory 34\n  Source: `annual-reports/2014-15.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf)`\n- Support an Australian health system that is research-led, evidence-based, efficient and\nsustainable.*\nTarget/s Methodology Reporting\nyears\n8 Develop and/or Qualitative assessment of NHMRC’s 2024–25\napprove public and role in developing, updating and/\n2025–26\nenvironmental health or approving guidelines that are\nand clinical practice timely, are based on a review of the 2026–27\nguidelines.* available evidence, follow transparent\n2027–28\ndevelopment and decision-making\nprocesses, and will promote health,\nprevent harm, encourage best practice\nand reduce waste.\n*This performance measure/target is included in the Portfolio Budget Statements.\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- Research is conducted responsibly, ethically and with integrity in Australia.*\nTarget/s Methodology Reporting\nyears\n10 Research integrity Quantitative assessment using 2024–25\nmatters are managed NHMRC’s annual survey of\n2025–26\nappropriately by Administering Institutions (Institutional\nAdministering Annual Compliance Report) to ensure 2026–27\nInstitutions in line with that the Code and its supporting\n2027–28\nthe requirements of the guides have been implemented in\nAustralian Code for the institutional processes, and qualitative\nResponsible Conduct of analysis of Australian Research\nResearch (the code).* Integrity Committee reviews of the\nprocesses used by Administering\nInstitutions to conduct integrity\ninvestigations in line with the\nrequirements of the Code.\n*This performance measure/target is included in the Portfolio Budget Statements.\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- LIST OF TABLES\nTable 1 NHMRC research funding 2013–14 21\nTable 2 Portfolio Budget Statement – NHMRC Expenses and Resources 30\nTable 3 Administration of NHMRC funding by research sector 31\nTable 4 Funding by Broad Research Area 32\nTable 5 Reduced information requirements for 2014 Project Grant applicants 33\nTable 6 Breakdown of year duration for 2013 applications 34\nTable 7 Research schemes expenditure in the National Health Priority Areas, 2013–14 46\nTable 8 Inspections under the RIHE and PHCR Acts 66\nTable 9 Deliverables, reference point and performance indicators 2013–14 72\nTable 10 Complaints to NHMRC 2013–14 77\nTable 11 Freedom of Information requests, 2013–14 83\nTable 12 Staff distribution by office at 30 June 84\nTable 13 Employee classification by gender 85\nTable 14 Consultancy contract expenditure from 2010–11 to 2013–14 90\n  Source: `annual-reports/2013-14.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/baa4d524-2b51-4ae9-8ae2-8667b250661d/upload_pdf/nh166_nhmrc_annual_report_2013_2014_accessible.pdf)`\n- Table 2 Portfolio Budget Statement – NHMRC Expenses and Resources\nBudget1 Actual\n2013–14 2013–14 Variation\n$’000 $’000 $’000\n(a) (b) (a)-(b)\nOutput Group 1.1: Health and Medical Research\nAdministered Items: Special Account\nMedical Research Endowment Account\nBalance carried from previous period 206,764 213,557 -6,793\nAppropriation receipts 771,187 774,487 -3,300\nNon-Appropriation receipts 11,050 9,521 1,529\nDepartmental Outputs\nOrdinary annual services (Appropriation Bill No.1) 40,273 40,239 34\nAppropriation receivable for existing outputs 13,005 12,581 424\nRevenues from other services 3,150 2,005 1,145\nExpenses not requiring appropriation in the Budget year2 1,801 1,877 -76\nOperating deficit (surplus) 1,400 1,200 200\nSubtotal for Output Group 1.1 1,048,630 1,055,467\nTotal for Outcome 1 1,048,630 1,055,467 -6,837\nDepartmental 59,629 57,902 1,727\nAdministered 989,001 997,565 -8,564\n  Source: `annual-reports/2013-14.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/baa4d524-2b51-4ae9-8ae2-8667b250661d/upload_pdf/nh166_nhmrc_annual_report_2013_2014_accessible.pdf)`\n\n### Strategic Priorities\n\n- Contents\nMessage from the CEO 1\nStatement of Preparation 2\nIntroduction 3\nRequirements for the Corporate Plan 3\nAbout NHMRC 4\nCapability 5\nRisk oversight and management 7\nNHMRC’s purposes 8\nEnvironment within which NHMRC operates 12\nNHMRC’s strategic direction 15\nMajor health issues 15\nStrategy for health and medical research 17\nStrategic priorities 19\nInvestment 19\nTranslation 20\nIntegrity 21\nPerformance: how NHMRC will achieve its purposes 22\nKey activities and performance measures 24\nNational Health and Medical Research Council Corporate Plan 2016–2017 v\n  Source: `corporate-plans/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/2d6f9cb6-500b-4651-a2ad-d7785ebffe53/upload_pdf/16390_nhmrc_-_nhmrc_corporate_plan_2016-17_0.pdf;fileType=application%2Fpdf)`\n- Contents\nMessage from the CEO 1\nStatement of preparation 2\nIntroduction 3\nRequirements for the Corporate Plan 3\nNHMRC’s purposes 4\nAbout NHMRC 6\nCapability 8\nRisk oversight and management 11\nEnvironment within which NHMRC operates 13\nNHMRC’s strategic direction 18\nMajor health issues 18\nStrategy for health and medical research 20\nStrategic priorities 22\nInvestment 22\nTranslation 23\nIntegrity 24\nPerformance: how NHMRC will achieve its purposes 25\nKey activities and performance measures 27\nAppendix 34\nNational Health and Medical Research Council Corporate Plan 2017–2018 iii\n  Source: `corporate-plans/2017-18.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/4ba2e828-a6a9-4c84-beab-a45c39967b6e/upload_pdf/17293_nhmrc_corporate_plan_2017-18-web.pdf;fileType=application%2Fpdf)`\n- Contents\nMessage from the CEO 3\nStatement of preparation 3\nNHMRC’s mission and purposes 4\nNHMRC’s strategic priorities 5\nStrategy for health and medical research 6\nKey activities 7\nInvestment 7\nTranslation 7\nIntegrity 8\nCorporate operations 8\nPerformance measures 9\nEnvironment, capability and risk 16\nNHMRC’s environment 16\nCapability 17\nRisk 19\n1\n  Source: `corporate-plans/2018-19.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf)`\n- Contents\nAcknowledgement of Country 2\nMessage from the CEO 3\nStatement of preparation 5\nOverview 7\nPurposes 8\nLegislative context 9\nStrategy 10\nOverview 11\nNHMRC Council and committees 12\nStrategic priorities 14\nHealth priorities 15\nCooperation 16\nConsumers and community groups 17\nIndustry organisations 17\nGovernment and other research funders 17\nResearchers and research organisations 18\nOperating context 20\nGovernance and accountability 21\nEnvironment 21\nRisk oversight and management 22\nCapability 27\nActivities 30\nKey activities 31\nPerformance 34\nPerformance measures 35\nAppendix A: List of requirements 40\nNational Health and Medical Research Council 1\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- Contents\nAcknowledgment of Country 4\nMessage from the CEO 5\nStatement of preparation 7\nNHMRC’s values 8\nOverview 9\nPurposes 10\nLegislative context 11\nStrategy 12\nOverview 13\nNHMRC Council and Committees 14\nStrategic priorities 16\nHealth priorities 18\nCooperation 20\nConsumers and community groups 21\nIndustry organisations 21\nGovernment relations and other research funders 21\nResearchers and research organisations 23\nOperating context 24\nGovernance and accountability 25\nEnvironment 26\nRisk oversight and management 28\nCapability 33\nActivities 38\nKey activities 40\nPerformance 44\nPerformance measures 46\nAppendix A: List of requirements 50\nNational Health and Medical Research Council | Corporate Plan 2025-26 3\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- Table 7: Corporate Plan requirements\nLegislation\nRequirement Page(s)\nReference\nIntroduction\n• statement of preparation: a statement that the plan is prepared for\n16E(2) 5\nparagraph 35(1)(b) of the PGPA Act\nPGPA Rule\n• the reporting period for which the plan is prepared\n• the reporting periods covered by the plan\nPurposes 16E(2)\n8\nPGPA Rule\nStrategy for health and medical research 16(2)\n11\n• a national strategy for medical research and public health research NHMRC Act\nHealth priorities\n• the CEO’s assessment of the major national health issues that are 16(2)\nlikely to arise during the period 15\nNHMRC Act\n• the manner in which the CEO proposes to perform their functions\nin dealing with those issues during the period\n16E(2)\nCooperation 16\nPGPA Rule\nOperating context\n• environment 21\n16E(2)\n• risk oversight and management, including key risks and its 22\nmanagement PGPA Rule\n27\n• capability\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- Table 1: NHMRC’s strategic priorities for 2024-2027\nStrategic priority Overview Planned actions in 2025–26\nSupport the Working with the Department Finalise and release the National Strategy\nNational Strategy of Health, Disability and within the next 12 months commencing\nAgeing to develop a new and with consultation on the draft National\ncohesive National Health and Strategy in the second half of 2025,\nMedical Research Strategy. including roundtables, workshops and\nwritten submissions.\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- Table 7: Corporate plan requirements\nRequirement Legislation reference Page(s)\nIntroduction 16E(2) PGPA Rule 7\n• statement of preparation: a statement that the plan is prepared\nfor paragraph 35(1)(b) of the PGPA Act\n• the reporting period for which the plan is prepared\n• the reporting periods covered by the plan\nPurposes 16E(2) PGPA Rule 10–11\nStrategy 16(2) NHMRC Act 16-17\n• a national strategy for medical research and public health research\nHealth priorities 16(2) NHMRC Act 18-19\n• the CEO’s assessment of the major national health issues that are\nlikely to arise during the period\n• the manner in which the CEO proposes to perform their functions\nin dealing with those issues during the period\nOperating context 16E(2) PGPA Rule\n• cooperation 20-23\n• subsidiaries (where applicable) N/A\n• environment 26\n• risk oversight, including key risks and its management 28-31\n• capability 33\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- LIST OF TABLES\nTable 1 NHMRC research funding 2013–14 21\nTable 2 Portfolio Budget Statement – NHMRC Expenses and Resources 30\nTable 3 Administration of NHMRC funding by research sector 31\nTable 4 Funding by Broad Research Area 32\nTable 5 Reduced information requirements for 2014 Project Grant applicants 33\nTable 6 Breakdown of year duration for 2013 applications 34\nTable 7 Research schemes expenditure in the National Health Priority Areas, 2013–14 46\nTable 8 Inspections under the RIHE and PHCR Acts 66\nTable 9 Deliverables, reference point and performance indicators 2013–14 72\nTable 10 Complaints to NHMRC 2013–14 77\nTable 11 Freedom of Information requests, 2013–14 83\nTable 12 Staff distribution by office at 30 June 84\nTable 13 Employee classification by gender 85\nTable 14 Consultancy contract expenditure from 2010–11 to 2013–14 90\n  Source: `annual-reports/2013-14.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/baa4d524-2b51-4ae9-8ae2-8667b250661d/upload_pdf/nh166_nhmrc_annual_report_2013_2014_accessible.pdf)`\n- LIST OF TABLES\nTable 1 NHMRC research funding 2014–15 22\nTable 2 Portfolio Budget Statement – NHMRC expenses and resources 34\nTable 3 Administration of NHMRC funding by research sector 35\nTable 4 Funding by broad research area 36\nTable 5 Breakdown of year duration for 2014 applications 37\nTable 6 Research scheme expenditure in the National Health Priority Areas, 2014–15 49\nTable 7 Inspections under the RIHE and PHCR Acts 72\nTable 8 Deliverables, reference point and performance indicators, 2014–15 78\nTable 9 Complaints about NHMRC funding or grant processes, 2014–15 83\nTable 10 Freedom of Information requests, 2014–15 87\nTable 11 Staff distribution by office as at 30 June 2015 89\nTable 12 Employee classification by gender 89\nTable 13 Employment status as at 30 June 2015 90\nTable 14 Consultancy contract expenditure from 2011–12 to 2014–15 94\n  Source: `annual-reports/2014-15.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf)`\n\n## KPIs, Targets, and Where They Are At\n\n- Support an Australian health system that is research-led, evidence-based, efficient and\nsustainable.*\nTarget/s Methodology Reporting\nyears\n8 Develop and/or Qualitative assessment of NHMRC’s 2024–25\napprove public and role in developing, updating and/\n2025–26\nenvironmental health or approving guidelines that are\nand clinical practice timely, are based on a review of the 2026–27\nguidelines.* available evidence, follow transparent\n2027–28\ndevelopment and decision-making\nprocesses, and will promote health,\nprevent harm, encourage best practice\nand reduce waste.\n*This performance measure/target is included in the Portfolio Budget Statements.\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- Research is conducted responsibly, ethically and with integrity in Australia.*\nTarget/s Methodology Reporting\nyears\n10 Research integrity Quantitative assessment using 2024–25\nmatters are managed NHMRC’s annual survey of\n2025–26\nappropriately by Administering Institutions (Institutional\nAdministering Annual Compliance Report) to ensure 2026–27\nInstitutions in line with that the Code and its supporting\n2027–28\nthe requirements of the guides have been implemented in\nAustralian Code for the institutional processes, and qualitative\nResponsible Conduct of analysis of Australian Research\nResearch (the code).* Integrity Committee reviews of the\nprocesses used by Administering\nInstitutions to conduct integrity\ninvestigations in line with the\nrequirements of the Code.\n*This performance measure/target is included in the Portfolio Budget Statements.\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- Support an Australian health system that is research-led, evidence based, efficient and\nsustainable.*\nTarget Methodology Measure type Reporting years\n8 Develop and/or Review of NHMRC records to identify Output 2025–26\napprove public and all CEO approvals/issuances in the 2026–27\nenvironmental health reporting period and NHMRC Council\n2027–28\nand clinical practice records that also demonstrate that\nguidelines.* Guidelines are developed consistent 2028–29\nwith NHMRC standards for guidelines\nunder subsection 7(1) of the NHMRC\nAct 1992, as well as records that\ndemonstrate progress of guidelines\nunder development.\n*This performance measure/target is included in the Portfolio Budget Statements.\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- Funding is categorised as\nthat will provide better ‘Indigenous health research’ through 2026–27\nhealth outcomes for a combination of Indigenous Research\n2027–28\nAboriginal and Torres Excellence Criteria assessment and\nStrait Islander people.* reviewing each funded grant against\na range of investigator provided data\nclassifications including fields of\nresearch, keywords, grant titles and\nmedia summaries.\n*This performance measure/target is included in the Portfolio Budget Statements, but has been\nmodified here to focus on new grants awarded only (previously the target included expenditure\non all active grants, as well as new grants awarded).\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- Table 7: Corporate Plan requirements\nLegislation\nRequirement Page(s)\nReference\nIntroduction\n• statement of preparation: a statement that the plan is prepared for\n16E(2) 5\nparagraph 35(1)(b) of the PGPA Act\nPGPA Rule\n• the reporting period for which the plan is prepared\n• the reporting periods covered by the plan\nPurposes 16E(2)\n8\nPGPA Rule\nStrategy for health and medical research 16(2)\n11\n• a national strategy for medical research and public health research NHMRC Act\nHealth priorities\n• the CEO’s assessment of the major national health issues that are 16(2)\nlikely to arise during the period 15\nNHMRC Act\n• the manner in which the CEO proposes to perform their functions\nin dealing with those issues during the period\n16E(2)\nCooperation 16\nPGPA Rule\nOperating context\n• environment 21\n16E(2)\n• risk oversight and management, including key risks and its 22\nmanagement PGPA Rule\n27\n• capability\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- Target Methodology Measure type Reporting years\n3 Better matching of peer Analysis of the peer review Efficiency and 2025–26\nreviewers to applications, process, including level of self- effectiveness 2026–27\nimproving application- reported suitability matching of\n2027–28\ncentric peer review in peer reviewers to applications,\napplicable schemes, and feedback from reviewers and 2028–29\nreduced burden on peer measurement of time spent on\nreviewers. peer review.\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- Target Methodology Measure type Reporting years\n5 3.4% of NHMRC’s annual Quantitative assessment of the Output 2025–26\ngrants awarded to lead percentage of new grants awarded 2026–27\nchief investigators of in the financial year to lead chief\n2027–28\nAboriginal and Torres investigators of Aboriginal and/or\nStrait Islander descent.\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- Target Methodology Measure type Reporting years\n7 Gender inequities Quantitative assessment of the Output and 2025–26\nin NHMRC funding number of grants, amount of effectiveness 2026–27\noutcomes are reduced. funding awarded and funded rates\n2027–28\nby gender, and whether measures\nhave been applied to reduce 2028–29\ngender disparities.\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- Research is conducted responsibly, ethically and with integrity in Australia.*\nTarget Methodology Measure type Reporting years\n11 Research integrity Quantitative assessment using Effectiveness 2025–26\nmatters are managed NHMRC’s annual survey of 2026–27\nappropriately by Administering Institutions\n2027–28\nAdministering (Institutional Annual Compliance\nInstitutions in line with Report) to ensure that the Code 2028–29\nthe requirements of and its supporting Guides have\nthe Australian Code been implemented in institutional\nfor the Responsible processes and that required\nConduct of Research.* notifications of integrity matters\nare made in line with the NHMRC\nResearch Integrity and Misconduct\nPolicy 2019.\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- Target Methodology Measure type Reporting years\n12 Compliance with Qualitative assessment from Effectiveness 2025–26\nregulatory requirements inspections and six-monthly reports 2026–27\nunder the Research is used to calculate the number and\n2027–28\nInvolving Human type of incidents of non-compliance\nEmbryos Act 2002. with licence conditions by each licence 2028–29\nholder in the period, as well as how\nquickly and effectively any actions to\nredress non-compliance (as required\nby the regulator) are actioned by the\nlicence holder.\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- Table 7: Corporate plan requirements\nRequirement Legislation reference Page(s)\nIntroduction 16E(2) PGPA Rule 7\n• statement of preparation: a statement that the plan is prepared\nfor paragraph 35(1)(b) of the PGPA Act\n• the reporting period for which the plan is prepared\n• the reporting periods covered by the plan\nPurposes 16E(2) PGPA Rule 10–11\nStrategy 16(2) NHMRC Act 16-17\n• a national strategy for medical research and public health research\nHealth priorities 16(2) NHMRC Act 18-19\n• the CEO’s assessment of the major national health issues that are\nlikely to arise during the period\n• the manner in which the CEO proposes to perform their functions\nin dealing with those issues during the period\nOperating context 16E(2) PGPA Rule\n• cooperation 20-23\n• subsidiaries (where applicable) N/A\n• environment 26\n• risk oversight, including key risks and its management 28-31\n• capability 33\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- INVESTMENT\nGoal 1: Support high quality health and medical research\nTarget 1 Allocate 50 per cent of total Medical research endowment Account (MreA) funding annually to Achieved\nNHMrC’s Project Grant scheme\nTarget 2 report annually on funding by broad research area, National Health Priority Areas and Australian Achieved\nGovernment priorities\nTarget 3 examine the role of philanthropic funding work ongoing\nTarget 4 run at least one Targeted Call for research annually work ongoing\nTarget 5 Periodic review of established funding schemes Achieved\nTarget 6 Completed reviews are presented to research Committee for consideration Achieved\nOutcome 1: N HMRC continued to support high quality health and medical research throughout\n2015–16.\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n- Goal 3: Boost dementia research\nTarget 1 establish a National institute for Dementia research Achieved\nTarget 2 Support the Clem Jones Centre for Ageing Dementia research Achieved\nTarget 3 work with the Australian research Council to build dementia research capacity Achieved\nTarget 4 Support large scale research in priority areas for dementia research Achieved\nOutcome 3: The Boosting Dementia Initiative is delivering on its commitment to enhance research\non dementia and to translate the results into policy and practice.\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n- Goal 4: Support collaborative, multidisciplinary approaches to solving health problems\nTarget 1 Promote and review management of multidisciplinary funding proposals work ongoing\nTarget 2 Undertake a collaborative, multidisciplinary tropical health research program work ongoing\nTarget 3 Develop an international engagement strategy to guide decisions on new collaborations Achieved\nTarget 4 finalise collaborative research funding with key international organisations Achieved\nOutcome 4: N HMRC supports collaborative, multidisciplinary approaches to solving health\nproblems through a number of different measures.\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n\n## Key Metrics\n\n| Values found | Evidence | Source |\n|---|---|---|\n| 12 Staff | LIST OF TABLES\nTable 1 NHMRC research funding 2013–14 21\nTable 2 Portfolio Budget Statement – NHMRC Expenses and Resources 30\nTable 3 Administration of NHMRC funding by research sector 31\nTable 4 Funding by Broad Research Area 32\nTable 5 Reduced information requirements for 2014 Project Grant applicants 33\nTable 6 Breakdown of year duration for 2013 applications 34\nTable 7 Research schemes expenditure in the National Health Priority Areas, 2013–1 | `annual-reports/2013-14.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/baa4d524-2b51-4ae9-8ae2-8667b250661d/upload_pdf/nh166_nhmrc_annual_report_2013_2014_accessible.pdf)` |\n| $2.8 million, 2.8 million | Table 25 Departmental financial performance\n30 June 2017 30 June 2016\n($’000) ($’000)\nOperating expenses 42,658 41,470\nOwn-source income (2,266) (1,248)\nGains (108) (430)\nNet cost of services 40,284 39,792\nRevenue from government (37,442) (40,237)\nOperating (deficit) / surplus (2,842) 445\nChange in asset revaluation surplus (124) 51\nTotal operating (deficit) / surplus (2,966) 496\nNHMRC’s operating result for 2016–17 was a deficit of $2.8 million. | `annual-reports/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf)` |\n| 11 Staff | LIST OF TABLES\nTable 1 NHMRC research funding 2014–15 22\nTable 2 Portfolio Budget Statement – NHMRC expenses and resources 34\nTable 3 Administration of NHMRC funding by research sector 35\nTable 4 Funding by broad research area 36\nTable 5 Breakdown of year duration for 2014 applications 37\nTable 6 Research scheme expenditure in the National Health Priority Areas, 2014–15 49\nTable 7 Inspections under the RIHE and PHCR Acts 72\nTable 8 Deliverables, | `annual-reports/2014-15.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf)` |\n| $7.0 million, 7.0 million | Annual Report of the National Health and Medical Research Council 2016–2017 121\ntroper\nLaicnanif\n5\nTRAP\nThe decrease in Administered expenses ($7.0 million) largely reflects delays in grants awarded from the\nBoosting Dementia Research budget measure and lower than expected awards from previous rounds of\nPartnership Projects, Hearing Loss Prevention Program and Program Grants. | `annual-reports/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf)` |\n| $3.0 million, 3.0 million | TABLE 16 DEPARTMENTAL FINANCIAL PERFORMANCE\n30 June 2013 30 June 2012\n($’000) ($’000)\nOperating expenses 45,488 46,651\nOwn-source income (2,436) (2,248)\nGains (147) (98)\nNet cost of services 42,905 44,305\nRevenue from government (39,863) (41,530)\nOperating (deficit) / surplus (3,042) (2,775)\nNHMRC’s operating result for 2012-13 was a loss of $3.0 million. | `other-pdfs/NationalHealthMedicalReasearchCouncil.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/70716/upload_pdf/NationalHealthMedicalReasearchCouncil.pdf)` |\n| $8.7m, $3.1 million, $0.6m, $0.5m, 3.1 million | Figure 2 Administered Funding: new grant commitments, appropriations, revenue,\ngrant payments and the MREA balance\n1,000\n900\n800\n700\n600\n500\n400\n300\n200\n100\n0\n20\nAnnual Report of the National Health and Medical Research Council 2013–2014 Annual Report of the National Health and Medical Research Council 2013–2014\nNOILLIM\n$\n2001–02 2002–03 2003–04 2004–05 2005–06 2006–07 2007–08 2008–09 2009–10 2010–11 2011–12 2012–13 2013–14\nFINANCIAL YEAR\nNew Gra | `annual-reports/2013-14.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/baa4d524-2b51-4ae9-8ae2-8667b250661d/upload_pdf/nh166_nhmrc_annual_report_2013_2014_accessible.pdf)` |\n| $13.2\nmillion, $7.5 million, $5.7 million, $0.6 million, $0.5\nmillion, $2 million | Figure 2 Medical research endowment account: new grant commitments, appropriations,\npayments and balance\n21\nAnnual Report of the National Health and Medical Research Council 2014–2015\nNOILLIM\n$\n1,000\n900\n800\n700\n600\n500\n400\n300\n200\n100\n0\n2002–03 2003–04 2004–05 2005–06 2006–07 2007–08 2008–09 2009–10 2010–11 2011–12 2012–13 2013–14 2014–15\nFINANCIAL YEAR\nNew Grant Commitments Revenue (Appropriation & Other Receipts)\nGrant Payments MREA Balance\nIn | `annual-reports/2014-15.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf)` |\n| $8.8 million, $2.8 million, $6.0 million, $0.5 million, $2 million, 8.8 million | Figure 2 Medical Research Endowment Account: new grant commitments, revenue,\ngrant payments and the MREA balance\n9\nNOILLIM\n$\n1,000\n900\n800\n700\n600\n500\n400\n300\n200\n100\n0\n200 6-07 200 7-08 200 8-09 200 9-10 201 0-11 201 1-12 201 2-13 201 3-14 201 4-15 201 5-16\nFINANCIAL YEAR\nNew Grant Commitments Grant Payments\nRevenue (Appropriation & Other Receipts) MREA Balance\nIn 2015–16, NHMRC also administered grant programs for activities related to dementia | `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)` |\n| 50 per cent | INVESTMENT\nGoal 1: Support high quality health and medical research\nTarget 1 Allocate 50 per cent of total Medical research endowment Account (MreA) funding annually to Achieved\nNHMrC’s Project Grant scheme\nTarget 2 report annually on funding by broad research area, National Health Priority Areas and Australian Achieved\nGovernment priorities\nTarget 3 examine the role of philanthropic funding work ongoing\nTarget 4 run at least one Targeted Call fo | `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)` |\n\n## Key Achievements\n\n- CORPORATE REPORTING PART 3\nQualitative Reference point\ndeliverables or target Performance\nPeriodic review Completed Public consultation on elements of the Project Grants scheme\nof established reviews are\nfunding presented NHMRC CEO Professor Warwick Anderson AM called for\nschemes to to Research submissions on the following elements of the Project Grants\ndetermine Committee for assessment process and funding rules:\nstrengths and consideration,\n• ‘not-for-further consideration’ and applicant response steps\nidentify where and\nimprovements implemented • duration of Project Grants funding.\ncan be made according to\nestablished The consultation opened on 8 December 2014 and closed on\ntimelines 27 March 2015.\n  Source: `annual-reports/2014-15.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf)`\n- AMRAB has delivered the inaugural Australian Medical Research and\nInnovation Strategy 2016–2021 (the Strategy) and the accompanying Australian\nMedical Research and Innovation Priorities 2016–2018 (the Priorities) to the Minister\nfor Health and Aged Care, announced by the Government in November 2016.9\nThe Strategy emphasises the complementary roles of the MRFF and NHMRC, and\nhighlights opportunities for possible future collaboration.\n  Source: `corporate-plans/2017-18.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/4ba2e828-a6a9-4c84-beab-a45c39967b6e/upload_pdf/17293_nhmrc_corporate_plan_2017-18-web.pdf;fileType=application%2Fpdf)`\n- Research is conducted responsibly, ethically and with integrity in Australia.*\nTarget/s Methodology Reporting\nyears\n10 Research integrity Quantitative assessment using 2024–25\nmatters are managed NHMRC’s annual survey of\n2025–26\nappropriately by Administering Institutions (Institutional\nAdministering Annual Compliance Report) to ensure 2026–27\nInstitutions in line with that the Code and its supporting\n2027–28\nthe requirements of the guides have been implemented in\nAustralian Code for the institutional processes, and qualitative\nResponsible Conduct of analysis of Australian Research\nResearch (the code).* Integrity Committee reviews of the\nprocesses used by Administering\nInstitutions to conduct integrity\ninvestigations in line with the\nrequirements of the Code.\n*This performance measure/target is included in the Portfolio Budget Statements.\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- Support an Australian health system that is research-led, evidence based, efficient and\nsustainable.*\nTarget Methodology Measure type Reporting years\n8 Develop and/or Review of NHMRC records to identify Output 2025–26\napprove public and all CEO approvals/issuances in the 2026–27\nenvironmental health reporting period and NHMRC Council\n2027–28\nand clinical practice records that also demonstrate that\nguidelines.* Guidelines are developed consistent 2028–29\nwith NHMRC standards for guidelines\nunder subsection 7(1) of the NHMRC\nAct 1992, as well as records that\ndemonstrate progress of guidelines\nunder development.\n*This performance measure/target is included in the Portfolio Budget Statements.\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- Research is conducted responsibly, ethically and with integrity in Australia.*\nTarget Methodology Measure type Reporting years\n11 Research integrity Quantitative assessment using Effectiveness 2025–26\nmatters are managed NHMRC’s annual survey of 2026–27\nappropriately by Administering Institutions\n2027–28\nAdministering (Institutional Annual Compliance\nInstitutions in line with Report) to ensure that the Code 2028–29\nthe requirements of and its supporting Guides have\nthe Australian Code been implemented in institutional\nfor the Responsible processes and that required\nConduct of Research.* notifications of integrity matters\nare made in line with the NHMRC\nResearch Integrity and Misconduct\nPolicy 2019.\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- BUSINESS PLANNING\nThe 2014–15 Annual Business Plan operationalised the Strategic Plan 2013–15 and the Health Portfolio\nBudget Statement for NHMRC 2014–15, by setting out what each branch and section was expected to\ndeliver to ensure the achievement of NHMRC’s strategic objectives.\n  Source: `annual-reports/2014-15.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf)`\n- INVESTMENT\nGoal 1: Support high quality health and medical research\nTarget 1 Allocate 50 per cent of total Medical research endowment Account (MreA) funding annually to Achieved\nNHMrC’s Project Grant scheme\nTarget 2 report annually on funding by broad research area, National Health Priority Areas and Australian Achieved\nGovernment priorities\nTarget 3 examine the role of philanthropic funding work ongoing\nTarget 4 run at least one Targeted Call for research annually work ongoing\nTarget 5 Periodic review of established funding schemes Achieved\nTarget 6 Completed reviews are presented to research Committee for consideration Achieved\nOutcome 1: N HMRC continued to support high quality health and medical research throughout\n2015–16.\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n- Annual Report of the National Health and Medical Research Council 2015–2016\nTrOPer\neCNAMrOfreP\n2\nTRAP\nTRANSLATION\nGoal 3: Develop public and environmental health and clinical advice\nTarget 1 Approve high quality clinical guidelines prepared by third parties Achieved\nTarget 2 Develop guidelines that address clinical, public and environmental health topics Achieved\nTarget 3 report on the quality of Australian clinical practice guidelines work ongoing\nTarget 4 Progress a new guideline development standard and methodology work ongoing\nOutcome 3: N HMRC continues to maintain its leadership role in the development and dissemination\nof public and environmental health and clinical advice.\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n- Goal 2: Strengthen process for managing research misconduct\nTarget 1 Prevent research misconduct and investigate complaints work ongoing\nTarget 2 Lead revision of the Australian Code for the Responsible Conduct of Research, 2007 work ongoing\nTarget 3 Undertake public consultation on a draft of the Australian Code for the Responsible Conduct of Research work ongoing\nTarget 4 revise the NHMRC Policy on Misconduct Related to NHMRC-funded Research work ongoing\nOutcome 2: N HMRC has made substantial progress toward supporting high ethical standards in\nhealth and medical research through strengthening the process for managing research\nmisconduct.\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n- Goal 3: Continue review of research ethics standards and guidelines\nTarget 1 ensure statements, codes and guidelines remain up-to-date and reflect best practice work ongoing\nTarget 2 review Section 3 of the National Statement on Ethical Conduct in Human research work ongoing\nTarget 3 review Ethical Guidelines on the Use of Assisted Reproductive Technology in Clinical Practice and work ongoing\nResearch\nTarget 4 Complete the Ethical Guidelines for Organ Transplantation from Deceased Donors Achieved\nTarget 5 Undertake public consultation on the development of Aboriginal and Torres Strait Islander Research work ongoing\nEthics Guidelines\nOutcome 3: S ignificant progress has been achieved with the review of research ethics standards\nand guidelines, many of which are associated with highly sensitive and complex issues.\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n- Annual Report of the National Health and Medical Research Council 2015–2016\nTrOPer\neCNAMrOfreP\n2\nTRAP\nTable 17 NHMRC commitments to research translation focussed funding programs\nGrant purpose Amount\nBuild Capacity $280,934,020\nCreate Knowledge $393,280,485\nTranslate Research $191,474,992\nTotal $865,689,498\nTarget 7: Report on the percentage of Project Grants with an innovation category\nscore of five or more\nCorporate Plan Report annually on the percentage of Project Grants awarded each year\nwith a ‘significance and/or innovation’ category score of five or more, to Achieved\nhighlight the proportion of grants that foster innovation.\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n- Health and Medical Research Council Act 1992\n(NHMRC Act) requires NHMRC to: The Health Portfolio Budget Statements 2016–17\nset out the intended outcomes for NHMRC, which\n• raise the standard of individual and public health are delivered through one program, as follows:\nthroughout Australia\nOutcome 1: Improved health and medical\n• foster the development of consistent health\nknowledge, including through funding research,\nstandards between the various states\ntranslating research findings into evidence-based\nand territories\nclinical practice, administering legislation governing\n• foster medical research and training and public research, issuing guidelines and advice for ethics in\nhealth research and training throughout Australia health and the promotion of public health.\n• foster consideration of ethical issues relating\nProgram 1.1 Health and Medical Research.\nto health.\n  Source: `annual-reports/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf)`\n\n## Key Issues, Risks, and Recommendations\n\n- Contents\nMessage from the CEO 1\nStatement of Preparation 2\nIntroduction 3\nRequirements for the Corporate Plan 3\nAbout NHMRC 4\nCapability 5\nRisk oversight and management 7\nNHMRC’s purposes 8\nEnvironment within which NHMRC operates 12\nNHMRC’s strategic direction 15\nMajor health issues 15\nStrategy for health and medical research 17\nStrategic priorities 19\nInvestment 19\nTranslation 20\nIntegrity 21\nPerformance: how NHMRC will achieve its purposes 22\nKey activities and performance measures 24\nNational Health and Medical Research Council Corporate Plan 2016–2017 v\n  Source: `corporate-plans/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/2d6f9cb6-500b-4651-a2ad-d7785ebffe53/upload_pdf/16390_nhmrc_-_nhmrc_corporate_plan_2016-17_0.pdf;fileType=application%2Fpdf)`\n- Contents\nMessage from the CEO 1\nStatement of preparation 2\nIntroduction 3\nRequirements for the Corporate Plan 3\nNHMRC’s purposes 4\nAbout NHMRC 6\nCapability 8\nRisk oversight and management 11\nEnvironment within which NHMRC operates 13\nNHMRC’s strategic direction 18\nMajor health issues 18\nStrategy for health and medical research 20\nStrategic priorities 22\nInvestment 22\nTranslation 23\nIntegrity 24\nPerformance: how NHMRC will achieve its purposes 25\nKey activities and performance measures 27\nAppendix 34\nNational Health and Medical Research Council Corporate Plan 2017–2018 iii\n  Source: `corporate-plans/2017-18.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/4ba2e828-a6a9-4c84-beab-a45c39967b6e/upload_pdf/17293_nhmrc_corporate_plan_2017-18-web.pdf;fileType=application%2Fpdf)`\n- Table 7: Corporate Plan requirements\nLegislation\nRequirement Page(s)\nReference\nIntroduction\n• statement of preparation: a statement that the plan is prepared for\n16E(2) 5\nparagraph 35(1)(b) of the PGPA Act\nPGPA Rule\n• the reporting period for which the plan is prepared\n• the reporting periods covered by the plan\nPurposes 16E(2)\n8\nPGPA Rule\nStrategy for health and medical research 16(2)\n11\n• a national strategy for medical research and public health research NHMRC Act\nHealth priorities\n• the CEO’s assessment of the major national health issues that are 16(2)\nlikely to arise during the period 15\nNHMRC Act\n• the manner in which the CEO proposes to perform their functions\nin dealing with those issues during the period\n16E(2)\nCooperation 16\nPGPA Rule\nOperating context\n• environment 21\n16E(2)\n• risk oversight and management, including key risks and its 22\nmanagement PGPA Rule\n27\n• capability\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- Table 7: Corporate plan requirements\nRequirement Legislation reference Page(s)\nIntroduction 16E(2) PGPA Rule 7\n• statement of preparation: a statement that the plan is prepared\nfor paragraph 35(1)(b) of the PGPA Act\n• the reporting period for which the plan is prepared\n• the reporting periods covered by the plan\nPurposes 16E(2) PGPA Rule 10–11\nStrategy 16(2) NHMRC Act 16-17\n• a national strategy for medical research and public health research\nHealth priorities 16(2) NHMRC Act 18-19\n• the CEO’s assessment of the major national health issues that are\nlikely to arise during the period\n• the manner in which the CEO proposes to perform their functions\nin dealing with those issues during the period\nOperating context 16E(2) PGPA Rule\n• cooperation 20-23\n• subsidiaries (where applicable) N/A\n• environment 26\n• risk oversight, including key risks and its management 28-31\n• capability 33\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- PART 5 APPENDIXES\nMREA Medical Research Endowment Account\nNAC NHMRC Audit Committee\nNHPA National Health Priority Area\nNHREC National Health Research Enabling Capabilities\nNHMRC National Health and Medical Research Council\nNIHR National Institute for Health Research\nNSFC National Natural Science Foundation of China\nOAIC Office of the Australian Information Commissioner\nOTA Organ and Tissue Authority\nPBS Portfolio Budget Statement\nPCHC Prevention and Community Health Committee\nPHCR Act Prohibition of Human Cloning for Reproduction Act 2002\nRGMS Research Grants Management System\nRIHE Act Research Involving Human Embryos Act 2002\nRMF Risk Management Framework\nRFA Request for Applications\nRTG Research Translation Group\nSES Senior Executive Service\nTRIP Translating Research into Practice\nTSANZ Transplantation Society of Australia and New Zealand\nWHS Work health and safety\n  Source: `annual-reports/2013-14.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/baa4d524-2b51-4ae9-8ae2-8667b250661d/upload_pdf/nh166_nhmrc_annual_report_2013_2014_accessible.pdf)`\n- 12(2) Statement of the main corporate governance practices in place Mandatory 76-81\n12(3) Names of the senior executive and their responsibilities Suggested 11-20\n12(3) Senior management committees and their roles Suggested 76-77\n12(3) Corporate and operational plans and associated performance Suggested 77-79\nreporting and review\n12(3) Internal audit arrangements including approach adopted to Suggested 80\nidentifying areas of significant financial or operational risk and\narrangements to manage those risks\n179\nAnnual Report of the National Health and Medical Research Council 2014–2015\n  Source: `annual-reports/2014-15.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf)`\n- Goal 2: Support the translation of health and medical research\nTarget 1 fund Partnerships for Better Health projects and centres work ongoing\nTarget 2 Promote the role of Advanced Health research and Translation Centres work ongoing\nTarget 3 Continue to address evidence-practice gaps work ongoing\nTarget 4 work with the Commonwealth, states and territories to identify issues of mutual concern work ongoing\nTarget 5 work with Australian Health Protection Principal Committee (AHPPC) to develop research preparedness work ongoing\nin response to infectious disease threats to health\nTarget 6 Publish an updated Statement on Consumer and Community Participation in Health and Medical Research work ongoing\nTarget 7 establish the Health Translation Advisory Committee Achieved\nTarget 8 Host the fourth research Translation Symposium Achieved\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n- Annual Report of the National Health and Medical Research Council 2015–2016 Annual Report of the National Health and Medical Research Council 2015–2016\nTrOPer\neCNAMrOfreP\n2\nTRAP\nGuideline Responsible organisation Description\nClinical practice Prostate Cancer Foundation These guidelines provide health\nguidelines: PSA Testing Australia and Cancer professionals access to evidence-based\nand Early Management of Council Australia recommendations for using the prostate\nTest-Detected Prostate specific antigen (PSA) blood test to assess\nCancer (recommendations) prostate cancer risk and manage test-\ndetected patients.\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n- The Council met three times throughout the reporting period:\nFirst Council meeting for the 2015–18 triennium (205th Session) – 22–23 September 2015\nMembers identified key strategic issues as well as the key challenges facing the Council over the\ncoming triennium.\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n- Starving bacteria-beating antibiotic\nresistance – Professor Andrew Abell\nUNIVERSITY/INSTITUTION: University of Adelaide\nYEAR PROJECT STARTED: 2011\nTYPE: Project Grant\nGRANT COST: $605,963\nThe World Health Organization has described antimicrobial\nresistance as one of the key global health issues facing\nour generation.2 The lack of new antibiotics coupled with\noverprescription has led to bacteria becoming increasingly\nresistant – rendering existing antibiotics less effective and\nplacing patients at greater risk of dying from common\ninfections.\n  Source: `annual-reports/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf)`\n- Contents\nMessage from the CEO 3\nStatement of preparation 3\nNHMRC’s mission and purposes 4\nNHMRC’s strategic priorities 5\nStrategy for health and medical research 6\nKey activities 7\nInvestment 7\nTranslation 7\nIntegrity 8\nCorporate operations 8\nPerformance measures 9\nEnvironment, capability and risk 16\nNHMRC’s environment 16\nCapability 17\nRisk 19\n1\n  Source: `corporate-plans/2018-19.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf)`\n- Contents\nAcknowledgement of Country 2\nMessage from the CEO 3\nStatement of preparation 5\nOverview 7\nPurposes 8\nLegislative context 9\nStrategy 10\nOverview 11\nNHMRC Council and committees 12\nStrategic priorities 14\nHealth priorities 15\nCooperation 16\nConsumers and community groups 17\nIndustry organisations 17\nGovernment and other research funders 17\nResearchers and research organisations 18\nOperating context 20\nGovernance and accountability 21\nEnvironment 21\nRisk oversight and management 22\nCapability 27\nActivities 30\nKey activities 31\nPerformance 34\nPerformance measures 35\nAppendix A: List of requirements 40\nNational Health and Medical Research Council 1\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- Strategic risks Operational risks\n26 Corporate Plan 2024–25 National Health and Medical Research Council\nytilibapaC\nRisk description Risk tolerance Primary control/s\nBuilding innovative Moderate Maintain an appropriate\ninformation and governance structure to oversee\ncommunications project management and budgets,\ntechnology (ICT) including regular review of risks\nto support business and issues.\ncapability exceeds\nDesign and test ICT solutions with\ntime, solutions\ninternal and external users and\noperate suboptimally\nimplement enhancements over\nor increase\ntime, as feasible and where most\nthe burden on\nneeded.\nstakeholders.\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- Contents\nAcknowledgment of Country 4\nMessage from the CEO 5\nStatement of preparation 7\nNHMRC’s values 8\nOverview 9\nPurposes 10\nLegislative context 11\nStrategy 12\nOverview 13\nNHMRC Council and Committees 14\nStrategic priorities 16\nHealth priorities 18\nCooperation 20\nConsumers and community groups 21\nIndustry organisations 21\nGovernment relations and other research funders 21\nResearchers and research organisations 23\nOperating context 24\nGovernance and accountability 25\nEnvironment 26\nRisk oversight and management 28\nCapability 33\nActivities 38\nKey activities 40\nPerformance 44\nPerformance measures 46\nAppendix A: List of requirements 50\nNational Health and Medical Research Council | Corporate Plan 2025-26 3\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n\n## Corporate Values and Operating Culture\n\n- Overarching values identified from stakeholder responses (column 1) and common subthemes\nBroad theme\nSubthemes\nRespect\nRespect for lived experience\nMutual respect\nRespect for different backgrounds\nRespect for different perspectives\nRespect for skills and knowledge\nRespect for consumer contributions through recognition and remuneration\nEquity\nConsumers treated as equal members of the team\nAddress disparities in research access\nImprove representativeness of research\nEquity of resourcing for consumer organisations\nAddressing/ acknowledging power imbalance between researchers and consumers\nDiversity\nInvolve consumers from a range of backgrounds and experiences\nIntersectionality\nResearch must reflect diversity of communities\nInvolvement of underrepresented/marginalised groups\nCultural safety\nInclusiveness\nListening\nAccessibility/ address barriers to access\nUsing accessible language\n  Source: `pages/announcements-index__18.html (https://www.nhmrc.gov.au/research-policy/consumer-and-community-involvement/review-statement-consumer-and-community-involvement-health-and-medical-research/online-engagement-report)`\n- ADWG Australian Drinking Water Guidelines\nAHEC Australian Health Ethics Committee\nAHRTC Advanced Health Research and Translation Centres\nAPP Australian Privacy Principles guidelines\nAPS Australian Public Service\nARIC Australian Research Integrity Committee\nCIRM California Institute for Regenerative Medicine\nCPRs Commonwealth Procurement Rules\nFOI Act Freedom of Information Act 1982\nGACD Global Alliance for Chronic Diseases\nGRP Grant Review Panel\nHCC Health Care Committee\nHFSP Human Frontier Science Program\nHGAC Human Genetics Advisory Committee\nHRCNZ Health Research Council of New Zealand\nHREC Human Research Ethics Committee\nHTA Health Technology Assessment\nMREA Medical Research Endowment Account\nNHMRC National Health and Medical Research Council\nNIHR National Institute for Health Research\nNSFC National Natural Science Foundation of China\n  Source: `annual-reports/2014-15.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf)`\n- APPENDIXES PART 5\nAPPENDIX 12: GLOSSARY AND ACRONYMS\nFor a comprehensive list of health-related definitions used in Australia, see the Department of Health\nthesaurus available at http://www.health.gov.au/internet/main/publishing.nsf/Content/health-thesaurus.htm\nADWG Australian Drinking Water Guidelines\nAHEC Australian Health Ethics Committee\nAPS Australian Public Service\nAPSC Australian Public Service Commission\nARIC Australian Research Integrity Committee\nCIRM California Institute for Regenerative Medicine\nCPGs Clinical practice guidelines\nCPRs Commonwealth Procurement Rules\nECF Early Career Fellowships\nFMA Act Financial Management and Accountability Act 1997\nFMIS Financial Management Information System\nFOI Act Freedom of information Act 1982\nGACD Global Alliances for Chronic Diseases\nGRP Grant Review Panel\nHCC Health Care Committee\nHFSP Human Frontier Science Program\n  Source: `annual-reports/2013-14.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/baa4d524-2b51-4ae9-8ae2-8667b250661d/upload_pdf/nh166_nhmrc_annual_report_2013_2014_accessible.pdf)`\n- Contents\nAcknowledgment of Country 4\nMessage from the CEO 5\nStatement of preparation 7\nNHMRC’s values 8\nOverview 9\nPurposes 10\nLegislative context 11\nStrategy 12\nOverview 13\nNHMRC Council and Committees 14\nStrategic priorities 16\nHealth priorities 18\nCooperation 20\nConsumers and community groups 21\nIndustry organisations 21\nGovernment relations and other research funders 21\nResearchers and research organisations 23\nOperating context 24\nGovernance and accountability 25\nEnvironment 26\nRisk oversight and management 28\nCapability 33\nActivities 38\nKey activities 40\nPerformance 44\nPerformance measures 46\nAppendix A: List of requirements 50\nNational Health and Medical Research Council | Corporate Plan 2025-26 3\n  Source: `corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)`\n- Annual Report of the National Health and Medical Research Council 2015–2016\nTrOPer\neCNAMrOfreP\n2\nTRAP\nINVESTMENT\nGoal 5: Participate in developing national strategies for research infrastructure investment\nTarget 1 Develop policies for national research infrastructure investment that will reduce duplication and work ongoing\nencourage collaboration\nTarget 2 Award eligible independent medical research institutes approximately 20 cents per dollar of the Achieved\ntotal yearly value of grants held\nOutcome 5: NHMRC continues to develop policies and invest in national research infrastructure.\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n- iv Annual Report of the National Health and Medical Research Council 2016–2017 Annual Report of the National Health and Medical Research Council 2016–2017\nstnetnoc\nContents\nAbout the report vii\nPART 1 OVERVIEW VIII\nChief Executive Officer’s review 2\nNHMRC overview 6\nResearch funding expenditure 8\nFunding snapshot 9\nPromoting excellence through NHMRC Awards 10\nTen of the best NHMRC research projects 16\nPART 2 ANNUAL PERFORMANCE STATEMENTS 20\nStatement by the accountable authority 22\nPurposes 23\nPerformance framework 24\nExpenses and resources 25\nResults summary 26\nPurpose 1: Investment 31\nPurpose 2: Translation 52\nPurpose 3: Integrity 70\nCase study: ART Working Committee 77\nPART 3 OPERATING ENVIRONMENT 78\nLegislative framework 80\nCorporate governance 81\nExternal scrutiny 87\nCompliance and assurance 88\nResearch integrity 92\nAccountability 94\n  Source: `annual-reports/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf)`\n- NHMRC Council and Committees\n(including shared NHMRC-MRFF advisory committees)\nYGETARTS\nSupport the National Strategy for Health and Medical Research\nSTRATEGIC\nPRIORITIES Harmonise the MRFF and MREA Maintain excellence in peer review\nBolster confidence\nChampion consumer involvement Embed equity in health research\nin research integrity\nFoster translation and commercialisation Promote prevention and public health\nHEALTH Aboriginal and Artificial Emerging health Multiple\nPRIORITIES Torres Strait intelligence threats and long-term\nIslander health in health emergencies conditions\nNOITAREPOOC\nConsumers and community groups Industry organisations\nCommonwealth agencies States and territories\nInternational and global partners Philanthropic organisations\nResearchers and research organisations\nGovernance and accountability TXETNOC\nGNITAREPO\nOPERATING ENVIRONMENT RISK OVERSIGHT AND MANAGEMENT\n  Source: `corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)`\n- This standard relieves not-for-profit public sector entities following disclosures specified in AASB 13 for assets within the\nscope of AASB 16 that are held primarily for their current service potential rather than to generate future net cash inflows:\n(a) for recurring and non-recurring fair value measurements categorised within Level 3 of the fair value hierarchy,\nquantitative information about the significant unobservable inputs used in the fair value measurement; (b) for recurring fair\nvalue measurements categorised within Level 3 of the fair value hierarchy, the amount of the total gains and losses for the\nperiod included in profit or loss that is attributable to the change in unrealised gains or losses relating to the assets held at the\nend of the reporting period, and the line item(s) in profit or loss in which those unrealised gains or losses are recognised; and\n  Source: `annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)`\n\n## Global Ideas and Case Study Inputs\n\n_No global-intelligence source text found yet. Run `CLAUDE/global-ideas-scraper.py <entity>` to populate case-study sources._\n\n## Source Artifacts Used\n\n- `corporate-plans/2016-17.pdf` - corporate-plans - https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/2d6f9cb6-500b-4651-a2ad-d7785ebffe53/upload_pdf/16390_nhmrc_-_nhmrc_corporate_plan_2016-17_0.pdf;fileType=application%2Fpdf\n- `corporate-plans/2017-18.pdf` - corporate-plans - https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/4ba2e828-a6a9-4c84-beab-a45c39967b6e/upload_pdf/17293_nhmrc_corporate_plan_2017-18-web.pdf;fileType=application%2Fpdf\n- `corporate-plans/2018-19.pdf` - corporate-plans - https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf\n- `corporate-plans/2024-25.pdf` - corporate-plans - https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf\n- `corporate-plans/2025-26.pdf` - corporate-plans - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf\n- `annual-reports/2013-14.pdf` - annual-reports - https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/baa4d524-2b51-4ae9-8ae2-8667b250661d/upload_pdf/nh166_nhmrc_annual_report_2013_2014_accessible.pdf\n- `annual-reports/2014-15.pdf` - annual-reports - https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf\n- `annual-reports/2015-16.pdf` - annual-reports - https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf\n- `annual-reports/2016-17.pdf` - annual-reports - https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf\n- `strategies/NHMRC_Gender_Equity_Strategy_FA.pdf` - strategies - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/NHMRC_Gender_Equity_Strategy_FA.pdf\n- `strategies/national_consumer_framework_web_504af020f2184.pdf` - strategies - https://www.canceraustralia.gov.au/sites/default/files/migrated-files/publications/national_consumer_framework_web_504af020f2184.pdf\n- `strategies/International-Engagement-Strategy-2023-2026.pdf` - strategies - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf\n- `reviews/final-report-national-scientific-committees.pdf` - reviews - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf\n- `pages/about.html` - pages - https://www.nhmrc.gov.au/about-us\n- `pages/announcements-index.html` - pages - https://www.nhmrc.gov.au/research-policy/consumer-and-community-involvement/review-statement-consumer-and-community-involvement-health-and-medical-research/completed-consultation-activities\n- `pages/announcements-index__14.html` - pages - https://www.nhmrc.gov.au/research-policy/consumer-and-community-involvement/review-statement-consumer-and-community-involvement-health-and-medical-research/completed-consultation-activities\n- `pages/announcements-index__15.html` - pages - https://www.nhmrc.gov.au/research-policy/consumer-and-community-involvement/review-statement-consumer-and-community-involvement-health-and-medical-research\n- `pages/announcements-index__16.html` - pages - https://www.nhmrc.gov.au/research-policy/consumer-and-community-involvement/review-statement-consumer-and-community-involvement-health-and-medical-research/videos-and-case-studies\n- `pages/announcements-index__17.html` - pages - https://www.nhmrc.gov.au/research-policy/consumer-and-community-involvement/review-statement-consumer-and-community-involvement-health-and-medical-research/timeline\n- `pages/announcements-index__18.html` - pages - https://www.nhmrc.gov.au/research-policy/consumer-and-community-involvement/review-statement-consumer-and-community-involvement-health-and-medical-research/online-engagement-report\n- `pages/announcements-index__19.html` - pages - https://www.nhmrc.gov.au/about-us/publications/review-2016-statement-consumer-and-community-involvement-health-and-medical-research-2025-consultation-report\n- `pages/announcements-index__20.html` - pages - https://www.nhmrc.gov.au/node/8162\n- `pages/announcements-index__21.html` - pages - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Consumer-statement/2025%20survey%20response%20-%20Canberra%20Health%20Service.pdf\n- `pages/announcements-index__22.html` - pages - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Consumer-statement/2025%20survey%20response%20-%20Research%20Australia.pdf\n- `pages/announcements-index__23.html` - pages - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Consumer-statement/2025%20survey%20response%20-%20National%20Rural%20Health.pdf\n- `pages/announcements-index__24.html` - pages - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Consumer-statement/2025%20survey%20response%20-%20Health%20Consumers%20NSW.pdf\n- `pages/announcements-index__25.html` - pages - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Consumer-statement/2025%20survey%20response%20-%20Health%20Consumers%20NSW-2.pdf\n- `pages/announcements-index__26.html` - pages - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Consumer-statement/2025%20survey%20response%20-%20Deakin%20University.pdf\n- `pages/announcements-index__27.html` - pages - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Consumer-statement/2025%20survey%20response%20-%20Council%20of%20Deans%20of%20Nursing%20and%20midwifery.pdf\n- `pages/announcements-index__28.html` - pages - https://www.nhmrc.gov.au/sites/default/files/documents/attachments/Consumer-statement/2025%20survey%20response%20-%20Australian%20Multicultural%20Health%20Collaborative.pdf\n- `pages/announcements-index__29.html` - pages - https://www.nhmrc.gov.au/sites/default/files/documents/consumer_statement_review_position_paper.pdf\n- `pages/annual-reports-index.html` - pages - https://www.nhmrc.gov.au/research-policy/embryo-research-licensing/embryo-research-licensing-committee-reports-parliament\n- `pages/corporate-plans-index.html` - pages - https://www.nhmrc.gov.au/about-us/corporate-plans-and-annual-reports\n- `pages/corporate-plans-index__00.html` - pages - https://www.nhmrc.gov.au/about-us/publications/nhmrc-corporate-plan-2025-26\n- `pages/corporate-plans-index__01.html` - pages - https://www.nhmrc.gov.au/about-us/publications/nhmrc-corporate-plan-2024-25\n- `pages/homepage.html` - pages - https://www.nhmrc.gov.au/about-us/leadership-and-governance/committees/embryo-research-licensing-committee\n- `pages/leadership.html` - pages - https://www.nhmrc.gov.au/about-us/leadership-and-governance/committees/embryo-research-licensing-committee\n- `pages/ministers.html` - pages - https://www.nhmrc.gov.au/funding/manage-your-funding/nhmrc-funding/administering-institutions\n- `pages/news-latest.html` - pages - https://www.nhmrc.gov.au/about-us/news-centre\n- `pages/publications-index.html` - pages - https://www.nhmrc.gov.au/about-us/publications\n- `pages/reforms-index.html` - pages - https://www.nhmrc.gov.au/research-policy/clinical-trial-reform\n- `pages/reforms-index__12.html` - pages - https://www.nhmrc.gov.au/research-policy/clinical-trial-reform\n- `pages/reforms-index__13.html` - pages - https://www.nhmrc.gov.au/file/14281/download?token=yf_EGIEL\n- `pages/strategies-index.html` - pages - https://www.nhmrc.gov.au/about-us/publications/international-engagement-strategy-2023-2026-strategic-opportunities\n- `pages/strategies-index__02.html` - pages - https://www.nhmrc.gov.au/about-us/publications/international-engagement-strategy-2023-2026-strategic-opportunities\n- `pages/strategies-index__03.html` - pages - https://www.nhmrc.gov.au/funding/data-research/outcomes-funding-rounds\n- `pages/strategies-index__04.html` - pages - https://www.nhmrc.gov.au/funding/outcomes-and-data-research\n- `pages/strategies-index__05.html` - pages - https://www.nhmrc.gov.au/funding/outcomes-and-data-research/research-funding-statistics-and-data\n- `pages/strategies-index__06.html` - pages - https://www.nhmrc.gov.au/node/8218/\n- `pages/strategies-index__07.html` - pages - https://www.nhmrc.gov.au/funding/international-collaborative-funding/international-engagement-strategy-and-activities\n- `pages/strategies-index__08.html` - pages - https://www.nhmrc.gov.au/funding/data-research/outcomes\n- `pages/strategies-index__09.html` - pages - https://www.nhmrc.gov.au/funding/outcomes-and-data-research/data-dictionary-and-data-glossary\n- `pages/strategies-index__10.html` - pages - https://www.nhmrc.gov.au/research-policy/gender-equity/nhmrc-gender-equity-strategy\n- `pages/strategies-index__11.html` - pages - https://www.nhmrc.gov.au/research-policy/research-priorities/framework-identifying-and-prioritising-targeted-calls-research\n- `pages/structure.html` - pages - https://www.nhmrc.gov.au/funding/manage-your-funding/mrff-funding/mrff-eligible-organisations\n- `other-pdfs/18845_2008-10.pdf` - other-pdfs - https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/HSTP018845_2008-10/upload_pdf/18845_2008-10.pdf\n- `other-pdfs/14428_2010-13.pdf` - other-pdfs - https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/HSTP014428_2010-13/upload_pdf/14428_2010-13.pdf\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pdf` - other-pdfs - https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/70716/upload_pdf/NationalHealthMedicalReasearchCouncil.pdf\n\n## Gaps To Fix\n\n- No global comparison/case-study sources found.",
  "legislation_md": "# National Health and Medical Research Council - Embryo Research and Licensing Committee - Acts and Legislation Discovery\n\n**Generated at**: 2026-05-09T21:11:26.202643+00:00\n**Entity ID**: B-001937\n**Jurisdiction**: Commonwealth\n**Portfolio**: Health, Disability and Ageing\n\n> This is an evidence-based discovery list from scraped department material. A mention does not always mean the department administers the legislation; high-confidence and official register links should be reviewed.\n\n## Summary\n\n- Source files scanned: 58\n- Unique legislation references found: 61\n\n| Type | Count |\n|---|---:|\n| Act | 61 |\n\n## Legislation References\n\n### National Health and Medical Research Council Act 1992\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 45\n**Register search**: https://www.legislation.gov.au/search?query=National+Health+and+Medical+Research+Council+Act+1992\n\n**Sources**:\n- `pages/corporate-plans-index.html`\n- `pages/strategies-index__09.html`\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `annual-reports/2015-16.pages.jsonl`\n- `annual-reports/2016-17.pages.jsonl`\n- `corporate-plans/2016-17.pages.jsonl`\n- `corporate-plans/2017-18.pages.jsonl`\n- `corporate-plans/2018-19.pages.jsonl`\n- `corporate-plans/2024-25.pages.jsonl`\n\n**Evidence contexts**:\n- 2019–20\n2018–19\n2018–19\n2017–18\n2017–18\n2010 to 2016\nCorporate Plans and Strategic Plans\na\nAnnual Reports\na\nNHMRC published its first 'Corporate Plan' in 2015, in line with the requirements of the\nPublic Governance, Performance and Accountability Act 2013\nand\nNational Health and Medical Research Council Act 1992\n(NHMRC Act). Before 2015, NHMRC published its national strategy for health and medical research, major national health issues, as well as its key actions, in a 'Strategic Plan' for the triennium. This was in line with the then requirements of the NHMRC Act.\n2\n  Source: `pages/corporate-plans-index.html`\n- Plans\nb\nAnnual Reports\nb\nBefore 2015, NHMRC published its national strategy for health and medical research, major national health issues, as well as its key actions, in a ‘Strategic Plan’ for the triennium. This was in line with the then requirements of the\nNational Health and Medical Research Council Act 1992\n.\n2007-2009\n2009–10\n2008–09\n2007–08\n2003–2006\n2006-07\n2005\n2004\n2003\n2000-2003\n2002\n2001\n2000\n1990s\nNHMRC Strategic Plans\nc\nNHMRC Annual Reports\nCommonwealth Department responsible for Health Annual Reports\nd\nNHMRC Reports upon work under the Medical Research\n  Source: `pages/corporate-plans-index.html`\n- esearch Endowment Act\ne\nc\nBefore 2015, NHMRC published its national strategy for health and medical research, major national health issues, as well as its key actions, in a 'Strategic Plan' for the triennium. This was in line with the then requirements of the\nNational Health and Medical Research Council Act 1992\n(NHMRC Act). NHMRC published its first Strategic Plan in 1993, the same year it became a Statutory Authority under the NHMRC Act.\nd\nBefore 1993, NHMRC was part of the Commonwealth Department of Health and reported accordingly.\ne\nThese documents report on the\n  Source: `pages/corporate-plans-index.html`\n- e may vary from the actual funds paid to Administering Institutions due to indexation of payments and other post award funding variations. Figures are typically GST exclusive.\nM\nMedical Research Endowment Account (MREA)\nA Special Account established under the\nNational Health and Medical Research Council Act 1992\n(NHMRC Act). The MREA is funded through government appropriations, which are allocated annually in the Federal Budget. These funds are transferred to the MREA to support research activities that align with the objectives of NHMRC's schemes and grant opportuni\n  Source: `pages/strategies-index__09.html`\n- RRA ACT 2600 www.nhmrc.gov.au\nDear Minister\nI am pleased to present you with the Annual Report of the National Health and\nMedical Research Council (NHMRC) for the year ended 30 June 2014.\nThe report has been prepared in accordance with subsection 83(1) of the National\nHealth and Medical Research Council Act 1992 (NHMRC Act) and the Requirements\nfor Annual Reports approved by the Joint Committee of Public Accounts and Audit\nunder subsections 63(2) and 70(2) of the Public Service Act 1999.\nThe report also details information required by other applicable legislation, in\n  Source: `annual-reports/2013-14.pages.jsonl`\n\n### Research Involving Human Embryos Act 2002\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 41\n**Register search**: https://www.legislation.gov.au/search?query=Research+Involving+Human+Embryos+Act+2002\n\n**Sources**:\n- `pages/annual-reports-index.html`\n- `pages/homepage.html`\n- `pages/leadership.html`\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `annual-reports/2015-16.pages.jsonl`\n- `annual-reports/2016-17.pages.jsonl`\n- `corporate-plans/2016-17.pages.jsonl`\n- `corporate-plans/2017-18.pages.jsonl`\n- `corporate-plans/2024-25.pages.jsonl`\n\n**Evidence contexts**:\n- Embryo Research Licensing Committee Reports to Parliament | NHMRC\n\nSection 19(3) of the\nResearch Involving Human Embryos Act 2002\n(the Act) requires the NHMRC Licensing Committee to table six-monthly reports in either House of Parliament on or before 30 June and 31 December each year, and at any other time as required by either House of Parliament. The reports must include information a\n  Source: `pages/annual-reports-index.html`\n- Embryo Research Licensing Committee | NHMRC\n\nThe NHMRC Embryo Research Licensing Committee (ERLC) administers the human embryo research regulatory framework established by the\nResearch Involving Human Embryos Act 2002\n(RIHE Act) and the\nProhibition of Human Cloning for Reproduction Act 2002\n(PHCR Act).\nThese Acts establish a regulatory framework to prohibit certain practices, such as human cloning, and regulate the uses of excess assisted reproductive technology (ART) embr\n  Source: `pages/homepage.html`\n- Embryo Research Licensing Committee | NHMRC\n\nThe NHMRC Embryo Research Licensing Committee (ERLC) administers the human embryo research regulatory framework established by the\nResearch Involving Human Embryos Act 2002\n(RIHE Act) and the\nProhibition of Human Cloning for Reproduction Act 2002\n(PHCR Act).\nThese Acts establish a regulatory framework to prohibit certain practices, such as human cloning, and regulate the uses of excess assisted reproductive technology (ART) embr\n  Source: `pages/leadership.html`\n- the National Health and Medical Research Council 2013–2014\n\n[page 18]\nPART 1 OVERVIEW\nNHMRC is an independent statutory agency operating under the NHMRC Act. It has statutory obligations\nunder the Prohibition of Human Cloning for Reproduction Act 2002 and the Research Involving Human\nEmbryos Act 2002.\nNHMRC is a prescribed agency under the Financial Management and Accountability Act 1997 and is subject\nto the Public Service Act 1999. From 1 July 2014, NHMRC will be a non-corporate Commonwealth entity for\nthe purposes of the Public Governance, Performance\n  Source: `annual-reports/2013-14.pages.jsonl`\n- or the 2012–15 triennium, NHMRC comprised the following six Principal Committees:\n• Australian Health Ethics Committee (required under the NHMRC Act)\n• Research Committee (required under the NHMRC Act)\n• Embryo Research Licensing Committee (required under the Research Involving Human Embryos Act 2002)\n• Human Genetics Advisory Committee\n• Health Care Committee\n• Prevention and Community Health Committee.\nThe terms of reference for the Principal Committees were gazetted by the then Minister for Health\non 28 March 2012. The Chair of each Principal Committee\n  Source: `annual-reports/2013-14.pages.jsonl`\n\n### Public Governance, Performance and Accountability Act 2013\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 35\n**Register search**: https://www.legislation.gov.au/search?query=Public+Governance%2C+Performance+and+Accountability+Act+2013\n\n**Sources**:\n- `pages/corporate-plans-index.html`\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `annual-reports/2015-16.pages.jsonl`\n- `annual-reports/2016-17.pages.jsonl`\n- `corporate-plans/2016-17.pages.jsonl`\n- `corporate-plans/2017-18.pages.jsonl`\n- `corporate-plans/2018-19.pages.jsonl`\n- `corporate-plans/2024-25.pages.jsonl`\n- `corporate-plans/2025-26.pages.jsonl`\n\n**Evidence contexts**:\n- Corporate plans and annual reports | NHMRC\n\nWe publish corporate plans and annual reports in line with the\nPublic Governance, Performance and Accountability Act 2013\n. Our corporate plan sets our direction and objectives. Our annual report shows how we have performed in achieving our objectives. Find a list below of our corporate documents dating back to 1938.\nCorporate plan\nOur corporate plan presents our national strate\n  Source: `pages/corporate-plans-index.html`\n- 023–24\n2022–23\n2022–23\n2021–22\n2021–22\n2020–21\n2020–21\n2019–20\n2019–20\n2018–19\n2018–19\n2017–18\n2017–18\n2010 to 2016\nCorporate Plans and Strategic Plans\na\nAnnual Reports\na\nNHMRC published its first 'Corporate Plan' in 2015, in line with the requirements of the\nPublic Governance, Performance and Accountability Act 2013\nand\nNational Health and Medical Research Council Act 1992\n(NHMRC Act). Before 2015, NHMRC published its national strategy for health and medical research, major national health issues, as well as its key actions, in a 'Strategic Plan' for the triennium. This\n  Source: `pages/corporate-plans-index.html`\n- nvolving Human\nEmbryos Act 2002.\nNHMRC is a prescribed agency under the Financial Management and Accountability Act 1997 and is subject\nto the Public Service Act 1999. From 1 July 2014, NHMRC will be a non-corporate Commonwealth entity for\nthe purposes of the Public Governance, Performance and Accountability Act 2013.\nCOUNCIL OF THE NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL\nThe Council of NHMRC is established under section 20 of the NHMRC Act. It provides advice to the\nCEO and performs any other functions conferred by the Minister or legislation. The Council of NHMRC\nc\n  Source: `annual-reports/2013-14.pages.jsonl`\n- hair reports to the\nCEO regularly.\nDuring the reporting period, the Audit Committee Charter was reviewed and updated. The committee\nendorsed the updated charter at its June 2014 meeting. The charter will be reviewed, however, following the\ncommencement of the Public Governance, Performance and Accountability Act 2013 on 1 July 2013.\nMembership of the NHMRC Audit Committee comprises an independent Chair, a practising chartered\naccountant, a member of the NHMRC Council or a Principal Committee, and the General Manager of the\nOffice of the NHMRC.\nParticipating observers incl\n  Source: `annual-reports/2013-14.pages.jsonl`\n- anagement Policy and Framework (RMF) was\ndeveloped in accordance with the international standard on risk management AS/NZS ISO 31000:2009\n– Risk Management Principles and Guidelines. The RMF will be reviewed early in 2014–15 to reflect the\nrequirements of the Public Governance, Performance and Accountability Act 2013.\nRisk management roles and responsibilities\nUnder NHMRC’s risk management policy, risk management is integrated into the daily activities of\nNHMRC staff. All senior executives are accountable for the effective implementation of the RMF and\nhave responsibility\n  Source: `annual-reports/2013-14.pages.jsonl`\n\n### Prohibition of Human Cloning for Reproduction Act 2002\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 32\n**Register search**: https://www.legislation.gov.au/search?query=Prohibition+of+Human+Cloning+for+Reproduction+Act+2002\n\n**Sources**:\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `annual-reports/2015-16.pages.jsonl`\n- `annual-reports/2016-17.pages.jsonl`\n- `corporate-plans/2017-18.pages.jsonl`\n- `corporate-plans/2024-25.pages.jsonl`\n- `corporate-plans/2025-26.pages.jsonl`\n- `other-pdfs/18845_2008-10.pages.jsonl`\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n**Evidence contexts**:\n- nsumers groups.\nFigure 1 Structure of NHMRC\n9\nAnnual Report of the National Health and Medical Research Council 2013–2014\n\n[page 18]\nPART 1 OVERVIEW\nNHMRC is an independent statutory agency operating under the NHMRC Act. It has statutory obligations\nunder the Prohibition of Human Cloning for Reproduction Act 2002 and the Research Involving Human\nEmbryos Act 2002.\nNHMRC is a prescribed agency under the Financial Management and Accountability Act 1997 and is subject\nto the Public Service Act 1999. From 1 July 2014, NHMRC will be a non-corporate Commonwealth entity for\nt\n  Source: `annual-reports/2013-14.pages.jsonl`\n- gencies\nAs at 30 June 2014, NHMRC has the following contingent liabilities:\nNHMRC has in place a deed of standing offer with a panel of investigators to provide investigation\nservices if serious breaches of the Research Involving Human Embryos Act 2002 or the Prohibition of\nHuman Cloning for Reproduction Act 2002 are identified.\nThe consequence of the contingency being triggered is estimated to be a cost of $150,000.\nUnquantifiable contingencies\nAt 30 June 2014, the NHMRC had no unquantifiable contingencies.\nSignificant remote contingencies\nThe NHMRC has no significan\n  Source: `annual-reports/2013-14.pages.jsonl`\n- As at 30 June 2014 the NHMRC has the following contingent liabilities:\nThe NHMRC has in place a deed of standing offer with a panel of investigators to provide investigation\nservices if serious breaches of the Research Involving Human Embryos Act 2002 or the Prohibition of\nHuman Cloning for Reproduction Act 2002 are identified.\nThe consequence of the contingency being triggered is estimated to be a cost of approximately $150,000.\nUnquantifiable Contingencies\nAt 30 June 2014, the NHMRC had no unquantifiable contingencies.\nSignificant Remote Contingencies\nThe NHMRC has\n  Source: `annual-reports/2013-14.pages.jsonl`\n- 14 Annual Report of the National Health and Medical Research Council 2013–2014\n\n[page 183]\nAPPENDIXES PART 5\nAPPENDIX 4:\nEMBRYO RESEARCH LICENSING COMMITTEE\nThe Embryo Research Licensing Committee oversees the Research Involving Human Embryos Act 2002\nand the Prohibition of Human Cloning for Reproduction Act 2002. The legislation prohibits certain practices,\nincluding human cloning for reproduction. It regulates use of excess human embryos created through\nassisted reproductive technology (ART), the creation of embryos by other means and use of such embryos\nfor researc\n  Source: `annual-reports/2013-14.pages.jsonl`\n- d to deliver on the strategic directions of managing\ninvestment in health and medical research, developing evidence based health advice,\nproviding advice on ethical practice in health care and the conduct of medical research and\nperforming functions under the Prohibition of Human Cloning for Reproduction Act 2002\nand the Research Involving Human Embryos Act 2002.\nThe report has been prepared in accordance with section 83 of the National Health and\nMedical Research Council Act 1992 (NHMRC Act), section 46 of the Public Governance,\nPerformance and Accountability Act 201\n  Source: `annual-reports/2014-15.pages.jsonl`\n\n### Public Service Act 1999\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 27\n**Register search**: https://www.legislation.gov.au/search?query=Public+Service+Act+1999\n\n**Sources**:\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `annual-reports/2015-16.pages.jsonl`\n- `annual-reports/2016-17.pages.jsonl`\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n**Evidence contexts**:\n- prepared in accordance with subsection 83(1) of the National\nHealth and Medical Research Council Act 1992 (NHMRC Act) and the Requirements\nfor Annual Reports approved by the Joint Committee of Public Accounts and Audit\nunder subsections 63(2) and 70(2) of the Public Service Act 1999.\nThe report also details information required by other applicable legislation, including\nthe Financial Management and Accountability Act 1997, the Freedom of Information\nAct 1982, the Occupational Health and Safety (Commonwealth Employment) Act\n1991, the Work\n  Source: `annual-reports/2013-14.pages.jsonl`\n- Annual Report was prepared in accordance\nwith section 83 of the National Health and Medical Research Council Act 1992 and the Requirements for\nAnnual Reports approved by the Joint Committee of Public Accounts and Audit under subsections 63(2) and\n70(2) of the Public Service Act 1999.\nIt is a record of NHMRC’s activities during 2013–14 and the performance and financial information presented\nin the 2013–14 NHMRC Portfolio (Agency) Budget Statement and 2013–14 NHMRC Portfolio Additional\nEstimates Statement.\nThe report is structured as follo\n  Source: `annual-reports/2013-14.pages.jsonl`\n- Act. It has statutory obligations\nunder the Prohibition of Human Cloning for Reproduction Act 2002 and the Research Involving Human\nEmbryos Act 2002.\nNHMRC is a prescribed agency under the Financial Management and Accountability Act 1997 and is subject\nto the Public Service Act 1999. From 1 July 2014, NHMRC will be a non-corporate Commonwealth entity for\nthe purposes of the Public Governance, Performance and Accountability Act 2013.\nCOUNCIL OF THE NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL\nThe Council of NHMRC is established under sect\n  Source: `annual-reports/2013-14.pages.jsonl`\n- so improved our\nability to recover funds if required.\nPUBLIC INTEREST DISCLOSURES\nThe NHMRC encourages employees to promptly report concerns or suspected fraud. The Whistleblower\nPolicy and Procedures were reviewed to ensure consistency with amendments to the Public Service Act\n1999 that took effect on 1 July 2013.\nNHMRC’s Whistleblower Procedures were later replaced following the introduction of the Public Interest\nDisclosure Act 2013 (the PID Act) on 15 January 2014. Information and interim arrangements in relation\nto the PID Act are a\n  Source: `annual-reports/2013-14.pages.jsonl`\n- ch Council 2013–2014\n\n[page 95]\nCORPORATE REPORTING PART 3\nSES EMPLOYMENT AGREEMENTS\nAs at 30 June 2014, eight SES Employment Agreements (common law contracts) were in place.\nOTHER EMPLOYMENT INSTRUMENTS\nThere were no determinations made under s. 24(1) of the Public Service Act 1999 between 1 July 2013\nand 30 June 2014.\nPERFORMANCE PAY\nThe Performance Partnerships Program operates with pay point progression available to employees\nwho achieve a satisfactory rating during the performance cycle, which runs from July to June each year.\nPerfo\n  Source: `annual-reports/2013-14.pages.jsonl`\n\n### Financial Management and Accountability Act 1997\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 18\n**Register search**: https://www.legislation.gov.au/search?query=Financial+Management+and+Accountability+Act+1997\n\n**Sources**:\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n**Evidence contexts**:\n- and the Requirements\nfor Annual Reports approved by the Joint Committee of Public Accounts and Audit\nunder subsections 63(2) and 70(2) of the Public Service Act 1999.\nThe report also details information required by other applicable legislation, including\nthe Financial Management and Accountability Act 1997, the Freedom of Information\nAct 1982, the Occupational Health and Safety (Commonwealth Employment) Act\n1991, the Work Health and Safety Act 2011, and all relevant amendments to these\nacts. It also contains the report of the Commissioner of Complaints to me, w\n  Source: `annual-reports/2013-14.pages.jsonl`\n- IEW\nNHMRC is an independent statutory agency operating under the NHMRC Act. It has statutory obligations\nunder the Prohibition of Human Cloning for Reproduction Act 2002 and the Research Involving Human\nEmbryos Act 2002.\nNHMRC is a prescribed agency under the Financial Management and Accountability Act 1997 and is subject\nto the Public Service Act 1999. From 1 July 2014, NHMRC will be a non-corporate Commonwealth entity for\nthe purposes of the Public Governance, Performance and Accountability Act 2013.\nCOUNCIL OF THE NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL\n  Source: `annual-reports/2013-14.pages.jsonl`\n- attended the meetings. NHMRC Office staff also attended Executive\nCommittee meetings to present papers. The Executive Committee is also the forum for the NHMRC\ncompliance and performance agenda, and monitored performance as part of the responsibilities of the\nFinancial Management and Accountability Act 1997 (FMA Act).\nAdditional Executive Committee meetings, chaired by the General Manager, met monthly to discuss matters\nconcerning the Office of the NHMRC, including business planning and corporate operations. The CEO and\nExecutive also met regularly with the Chai\n  Source: `annual-reports/2013-14.pages.jsonl`\n- Government policy and on continuing funding by Parliament for the NHMRC’s administration and programs.\n1.2 Basis of preparation of the financial statements\nThe financial statements are general purpose financial statements and are required by section 49 of the\nFinancial Management and Accountability Act 1997.\nThe Financial Statements have been prepared in accordance with:\na) Finance Minister’s Orders (FMOs) for reporting periods ending on or after 1 July 2011; and\nb) Australian Accounting Standards and Interpretations issued by the Australian Accounting Standards\n  Source: `annual-reports/2013-14.pages.jsonl`\n- 186\nAvailable for payments 997,565 976,583\nDecreases:\nAdministered\nPayments made for medical research 863,417 763,026\nTotal administered 863,417 763,026\nTotal decreases 863,417 763,026\nTotal balance carried to the next period 134,148 213,557\n1. Appropriation: Financial Management and Accountability Act 1997 section 21\nEstablishing Instrument: National Health and Medical Research Council Act 1992; section 49\nPurpose: to provide assistance (subject to the National Health and Medical Research Council Act 1992):\n– to Departments of the Commonwealth, or of a State, e\n  Source: `annual-reports/2013-14.pages.jsonl`\n\n### Administer the Research Involving Human Embryos Act 2002\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 10\n**Register search**: https://www.legislation.gov.au/search?query=Administer+the+Research+Involving+Human+Embryos+Act+2002\n\n**Sources**:\n- `annual-reports/2015-16.pages.jsonl`\n- `annual-reports/2016-17.pages.jsonl`\n- `corporate-plans/2017-18.pages.jsonl`\n- `corporate-plans/2018-19.pages.jsonl`\n- `corporate-plans/2024-25.pages.jsonl`\n- `corporate-plans/2025-26.pages.jsonl`\n\n**Evidence contexts**:\n- l and Torres Strait Islander Research work ongoing\nEthics Guidelines\nOutcome 3: S ignificant progress has been achieved with the review of research ethics standards\nand guidelines, many of which are associated with highly sensitive and complex issues.\nGoal 4: Administer the Research Involving Human Embryos Act 2002 and the Prohibition of Human\nCloning for Reproduction Act 2002\nTarget 1 Stakeholders demonstrate continued understanding of regulatory requirements work ongoing\nTarget 2 implement new processes to decrease the burden of red tape on businesses work ongoing\nOut\n  Source: `annual-reports/2015-16.pages.jsonl`\n- by\nthe sectors.\n82\n\n[page 91]\nAnnual Report of the National Health and Medical Research Council 2015–2016\nTrOPer\neCNAMrOfreP\n2\nTRAP\nGOAL 4: ADMINISTER THE RESEARCH INVOLVING HUMAN EMBRYOS ACT 2002\nAND THE PROHIBITION OF HUMAN CLONING FOR REPRODUCTION ACT 2002\nAdminister the Research Involving Human Embryos Act 2002 and the Activity 3.4 NHMRC\nProhibition of Human Cloning for Reproduction Act 2002. Corporate Plan\nNHMRC will continue to administer the Research Involving Human Portfolio Budget\nEmbryos Act 2002 (RIHE Act) and the Prohibition of Human Cloning for Statement—\nR\n  Source: `annual-reports/2015-16.pages.jsonl`\n- protocols and documents without requiring prior approval\nfrom the committee. This will reduce the time between identifying and implementing required changes.\nThe committee will monitor the effect of these processes and make amendments as required.\nOutcome 4: Administer the Research Involving Human Embryos Act 2002 and the\nProhibition of Human Cloning for Reproduction Act 2002\nDuring 2015–16 the Embryo Research Licensing Committee has fulfilled its functions, and through NHMRC,\ncontinued to administer the legislation. Stakeholders indicated that they are satisfied with\n  Source: `annual-reports/2015-16.pages.jsonl`\n- vision of research ethics guidelines Achieved\nfor research involving Aboriginal and Torres Strait Islander peoples\nTarget 5 Finalise and release the Principles and guidelines for the care and use of non- Achieved\nhuman primates for scientific purposes\nGoal 4: Administer the Research Involving Human Embryos Act 2002 and the Prohibition of Human\nCloning for Reproduction Act 2002\nTarget 1 Stakeholders demonstrate a continued understanding of regulatory Work ongoing\nrequirements\nTarget 2 Implement processes to decrease the burden of red tape on businesses Work ongoing\nTarge\n  Source: `annual-reports/2016-17.pages.jsonl`\n- ttee, with advice from an expert NHMRC working committee. The review culminated\nin the finalisation of the Principles and guidelines for the care and use of non-human primates for scientific\npurposes, which was released on 20 September 2016.\nIntegrity goal 4: Administer the Research Involving Human Embryos Act 2002 and the Prohibition of\nHuman Cloning for Reproduction Act 2002\nActivity 3.4 Corporate plan\np. 35\nAdminister the Research Involving Human Embryos Act 2002 and the Prohibition of\nHuman Cloning for Reproduction Act 2002\nProgram objective E Portfolio budget\nstate\n  Source: `annual-reports/2016-17.pages.jsonl`\n\n### Work Health and Safety Act 2011\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 9\n**Register search**: https://www.legislation.gov.au/search?query=Work+Health+and+Safety+Act+2011\n\n**Sources**:\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `annual-reports/2016-17.pages.jsonl`\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n**Evidence contexts**:\n- 1999.\nThe report also details information required by other applicable legislation, including\nthe Financial Management and Accountability Act 1997, the Freedom of Information\nAct 1982, the Occupational Health and Safety (Commonwealth Employment) Act\n1991, the Work Health and Safety Act 2011, and all relevant amendments to these\nacts. It also contains the report of the Commissioner of Complaints to me, which is\nprovided under section 68 of the NHMRC Act.\nNHMRC has prepared fraud risk assessments and fraud control plans and has in\nplace appropriat\n  Source: `annual-reports/2013-14.pages.jsonl`\n- a good\nawareness of their responsibilities with regard to health and safety, and their own health and wellbeing.\nThere were two NHMRC workers’ compensation claims lodged and accepted in 2013–14.\nDuring 2013–14, no incidents were reported to Comcare under the Work Health and Safety Act 2011\n(WHS Act). There were no notices given to NHMRC under Part 10 of the WHS Act and there were no\ninvestigations conducted under the WHS Act.\n87\nAnnual Report of the National Health and Medical Research Council 2013–2014\n\n[page 96]\nPART 3 CORPORATE REPORTING\nDIS\n  Source: `annual-reports/2013-14.pages.jsonl`\n- s cases for action, 6, 46 wind turbines, human health review of evidence,\nStrategy Forum, 70 3, 56\nStreamlining Application and Assessment Project, Women in Health Science Committee, 4, 33, 180\n3, 33 work health and safety, 87\nstructure, organisational, 9, 10 Work Health and Safety Act 2011, 87\nsuicide prevention, 49, 52, 53, 72, workers compensation claims, 87\nworkforce planning, 84\nworkshops, 184\nT\ntargeted calls for research, 48, 53 Y\ntraining, staff see education and training, staff\nTranslating Research into Practice (TRIP) Fellow- year ahea\n  Source: `annual-reports/2013-14.pages.jsonl`\n- and also details\ninformation required by other applicable legislation, including the Public Governance,\nPerformance and Accountability Act 2013, the Freedom of Information Act 1982, the\nOccupational Health and Safety (Commonwealth Employment) Act 1991 and the Work\nHealth and Safety Act 2011.\nI certify that NHMRC has prepared fraud risk assessments and fraud control plans\nand has in place appropriate fraud prevention, detection, investigation, reporting and\ndata collection procedures and processes to meet its specific needs and comply with\nthe Co\n  Source: `annual-reports/2014-15.pages.jsonl`\n- C have\na good awareness of their responsibilities with regard to health and safety and to their own health and\nwellbeing.\nThere was one workers’ compensation claim lodged and accepted in 2014–15.\nDuring 2013–14, no incidents were reported to Comcare under the Work Health and Safety Act 2011 (WHS\nAct). There were no notices given to NHMRC under Part 10 of the WHS Act and there were no investigations\nconducted under the WHS Act.\nDISABILITY REPORTING\nSince 1994, Commonwealth departments and agencies have reported on their performance as policy\nadvi\n  Source: `annual-reports/2014-15.pages.jsonl`\n\n### Freedom of Information Act 1982\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 8\n**Register search**: https://www.legislation.gov.au/search?query=Freedom+of+Information+Act+1982\n\n**Sources**:\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `annual-reports/2015-16.pages.jsonl`\n- `annual-reports/2016-17.pages.jsonl`\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n**Evidence contexts**:\n- he Joint Committee of Public Accounts and Audit\nunder subsections 63(2) and 70(2) of the Public Service Act 1999.\nThe report also details information required by other applicable legislation, including\nthe Financial Management and Accountability Act 1997, the Freedom of Information\nAct 1982, the Occupational Health and Safety (Commonwealth Employment) Act\n1991, the Work Health and Safety Act 2011, and all relevant amendments to these\nacts. It also contains the report of the Commissioner of Complaints to me, which is\nprovided under section 68 of\n  Source: `annual-reports/2013-14.pages.jsonl`\n- acy Act in 2013–14.\n82\nAnnual Report of the National Health and Medical Research Council 2013–2014 Annual Report of the National Health and Medical Research Council 2013–2014\n\n[page 91]\nCORPORATE REPORTING PART 3\nFREEDOM OF INFORMATION\nAgencies subject to the Freedom of Information Act 1982 (FOI Act) are required to publish information to the\npublic as part of the Information Publication Scheme (IPS). This requirement is in Part II of the FOI Act and\nhas replaced the former requirement to publish a section 8 statement in agency annual reports. T\n  Source: `annual-reports/2013-14.pages.jsonl`\n- 70(2) of the Public Service Act 1999.\nThe report includes the matters set out in section 83 of the NHMRC Act, and also details\ninformation required by other applicable legislation, including the Public Governance,\nPerformance and Accountability Act 2013, the Freedom of Information Act 1982, the\nOccupational Health and Safety (Commonwealth Employment) Act 1991 and the Work\nHealth and Safety Act 2011.\nI certify that NHMRC has prepared fraud risk assessments and fraud control plans\nand has in place appropriate fraud prevention, detection, investig\n  Source: `annual-reports/2014-15.pages.jsonl`\n- acy Act in 2014–15.\n86\nAnnual Report of the National Health and Medical Research Council 2014–2015 Annual Report of the National Health and Medical Research Council 2014–2015\n\n[page 95]\nCORPORATE REPORTING PART 3\nFREEDOM OF INFORMATION\nAgencies subject to the Freedom of Information Act 1982 (FOI Act) are required to publish information to the\npublic as part of the Information Publication Scheme (IPS). This requirement is in Part II of the FOI Act and\nhas replaced the former requirement to publish a section 8 statement in agency annual reports. T\n  Source: `annual-reports/2014-15.pages.jsonl`\n- ffice of the Australian Information Commissioner (OIAC) under\nsection 30 of the Privacy Act 1988 in 2015–16. No determinations were served on NHMRC by the OAIC\nunder section 52 of the Privacy Act 1988 in 2015–16.\nFREEDOM OF INFORMATION\nAgencies subject to the Freedom of Information Act 1982 (FOI Act) are required to publish information to the\npublic as part of the Information Publication Scheme (IPS). This requirement is in Part II of the FOI Act and\nhas replaced the former requirement to publish a section 8 statement in agency annual reports. T\n  Source: `annual-reports/2015-16.pages.jsonl`\n\n### Medical Research Endowment Act 1937\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 8\n**Register search**: https://www.legislation.gov.au/search?query=Medical+Research+Endowment+Act+1937\n\n**Sources**:\n- `pages/corporate-plans-index.html`\n\n**Evidence contexts**:\n- record of our activities for the reporting period.\nFind our most recent\nannual reports on the Publications page\n.\nCorporate documents from 1930s to today\nWe have corporate documents dating back to 1938, when we first presented a report to Parliament under the\nMedical Research Endowment Act 1937\n.\nBelow is a list of corporate documents from 1938 to today. We have included links to the published documents where available online.\n2017 to current\nCorporate Plans\nAnnual Reports\n2025–26\nAvailable in late 2026\n2024–25\n2024–25\n2023–24\n2023–24\n2022–23\n2022–2\n  Source: `pages/corporate-plans-index.html`\n- its first Strategic Plan in 1993, the same year it became a Statutory Authority under the NHMRC Act.\nd\nBefore 1993, NHMRC was part of the Commonwealth Department of Health and reported accordingly.\ne\nThese documents report on the annual administration of the\nMedical Research Endowment Act 1937\n, including details on grants paid for medical research from the Medical Research Endowment Fund. This report ceased after 1992, as the Medical Research Endowment Act was repealed by the NHMRC Act.\n1997–2000\n1999\n1998\n1997\n1994–1996\n1996\n1995\n1994\n1993–1994\n1\n  Source: `pages/corporate-plans-index.html`\n- nsible for Health Annual Reports\nd\nNHMRC Reports upon work under the Medical Research Endowment Act\ne\nd\nBefore 1993, NHMRC was part of the Commonwealth Department of Health and reported accordingly.\ne\nThese documents report on the annual administration of the\nMedical Research Endowment Act 1937\n, including details on grants paid for medical research from the Medical Research Endowment Fund. This report ceased after 1992, as the Medical Research Endowment Act was repealed by the NHMRC Act.\n1989-90\n1989\n1988-89\n1988\n1987-88\n1987\n1986-87\n1986\n1985-86\n1\n  Source: `pages/corporate-plans-index.html`\n- nsible for Health Annual Reports\nd\nNHMRC Reports upon work under the Medical Research Endowment Act\ne\nd\nBefore 1993, NHMRC was part of the Commonwealth Department of Health and reported accordingly.\ne\nThese documents report on the annual administration of the\nMedical Research Endowment Act 1937\n, including details on grants paid for medical research from the Medical Research Endowment Fund. This report ceased after 1992, as the Medical Research Endowment Act was repealed by the NHMRC Act.\n1979-80\n1979\n1978-79\n1978\n1977-78\n1977\n1976-77\n1976\n1975-76\n1\n  Source: `pages/corporate-plans-index.html`\n- nsible for Health Annual Reports\nd\nNHMRC Reports upon work under the Medical Research Endowment Act\ne\nd\nBefore 1993, NHMRC was part of the Commonwealth Department of Health and reported accordingly.\ne\nThese documents report on the annual administration of the\nMedical Research Endowment Act 1937\n, including details on grants paid for medical research from the Medical Research Endowment Fund. This report ceased after 1992, as the Medical Research Endowment Act was repealed by the NHMRC Act.\n1969-70\n1969\n1968-69\n1968\n1967-68\n1967\n1966-67\n1966\n1965-66\n1\n  Source: `pages/corporate-plans-index.html`\n\n### RIHE Act) and the Prohibition of Human Cloning for Reproduction Act 2002\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 7\n**Register search**: https://www.legislation.gov.au/search?query=RIHE+Act%29+and+the+Prohibition+of+Human+Cloning+for+Reproduction+Act+2002\n\n**Sources**:\n- `pages/homepage.html`\n- `pages/leadership.html`\n- `annual-reports/2016-17.pages.jsonl`\n- `corporate-plans/2016-17.pages.jsonl`\n- `corporate-plans/2017-18.pages.jsonl`\n- `corporate-plans/2024-25.pages.jsonl`\n- `corporate-plans/2025-26.pages.jsonl`\n\n**Evidence contexts**:\n- Embryo Research Licensing Committee | NHMRC\n\nThe NHMRC Embryo Research Licensing Committee (ERLC) administers the human embryo research regulatory framework established by the\nResearch Involving Human Embryos Act 2002\n(RIHE Act) and the\nProhibition of Human Cloning for Reproduction Act 2002\n(PHCR Act).\nThese Acts establish a regulatory framework to prohibit certain practices, such as human cloning, and regulate the uses of excess assisted reproductive technology (ART) embryos, the creation or uses of other human embryos created through processes\n  Source: `pages/homepage.html`\n- Embryo Research Licensing Committee | NHMRC\n\nThe NHMRC Embryo Research Licensing Committee (ERLC) administers the human embryo research regulatory framework established by the\nResearch Involving Human Embryos Act 2002\n(RIHE Act) and the\nProhibition of Human Cloning for Reproduction Act 2002\n(PHCR Act).\nThese Acts establish a regulatory framework to prohibit certain practices, such as human cloning, and regulate the uses of excess assisted reproductive technology (ART) embryos, the creation or uses of other human embryos created through processes\n  Source: `pages/leadership.html`\n- e Prohibition of\nHuman Cloning for Reproduction Act 2002\nProgram objective E Portfolio budget\nstatements\nPromoting the highest ethical standards in health and medical research\np. 396\nNHMRC continues to administer the Research Involving Human Embryos Act 2002\n(RIHE Act) and the Prohibition of Human Cloning for Reproduction Act 2002 (PHCR\nAct), which prohibit certain practices, including human cloning for reproduction, and\nrestrict other practices relating to reproductive technology and research.\nTarget 1: Stakeholders demonstrate a continued understanding of regulatory requirements\nCorp\n  Source: `annual-reports/2016-17.pages.jsonl`\n- ed by legislation, the responsible\nminister may establish non-statutory Principal Committees to assist the Council.\nFor the triennium that commenced in July 2015, two new Principal Committees\n2 Section 35 NHMRC Act\n3 Research Involving Human Embryos Act 2002 (RIHE Act) and the Prohibition of Human Cloning for\nReproduction Act 2002 (PHCR Act).\n4 Corporate Plan 2016–2017\n\n[page 11]\nwere established: the Health Innovation Advisory Committee (HIAC) and the\nHealth Translation Advisory Committee (HTAC). They reflect NHMRC’s strategic\npriorities related to (i) the development, commercialisati\n  Source: `corporate-plans/2016-17.pages.jsonl`\n- ncipal Committees were established:\nthe Health Innovation Advisory Committee (HIAC) and the Health Translation\nAdvisory Committee (HTAC). They reflect NHMRC’s strategic priorities related to\n5 Section 35 NHMRC Act.\n6 Research Involving Human Embryos Act 2002 (RIHE Act) and the Prohibition of Human Cloning for Reproduction Act\n2002 (PHCR Act).\n6 National Health and Medical Research Council Corporate Plan 2017–2018\n\n[page 13]\n(i) the development, commercialisation and uptake of innovative technologies and\npractices and (ii) the effective translation of evidence to improve clinical outcom\n  Source: `corporate-plans/2017-18.pages.jsonl`\n\n### Environmental Protection and Biodiversity Conservation Act 1999\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 5\n**Register search**: https://www.legislation.gov.au/search?query=Environmental+Protection+and+Biodiversity+Conservation+Act+1999\n\n**Sources**:\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `annual-reports/2015-16.pages.jsonl`\n- `annual-reports/2016-17.pages.jsonl`\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n**Evidence contexts**:\n- t Policy to cover the activities, products and\nservices of its office-based operations at both the Canberra and Melbourne offices. NHMRC’s Environmental\nManagement Policy is based on international and domestic legislation, policies and standards, including:\n• Environmental Protection and Biodiversity Conservation Act 1999\n• AS/NZS ISO 14001:2004 – Environmental Management Systems\n• Australian Government Energy Efficiency in Government Operations (EEGO) Policy\nThe Environmental Management Policy enables NHMRC to incorporate environmental considerations such\nas energy and water\n  Source: `annual-reports/2013-14.pages.jsonl`\n- licy to cover the activities, products and\nservices of its office-based operations at both the Canberra and Melbourne offices. NHMRC’s Environmental\nManagement Policy is based on international and domestic legislation, policies and standards, including:\n• the Environmental Protection and Biodiversity Conservation Act 1999\n• AS/NZS ISO 14001:2004 Environmental management systems\n• Australian Government Energy Efficiency in Government Operations (EEGO) Policy.\nThe Environmental Management Policy enables NHMRC to incorporate environmental considerations such\nas energy and water c\n  Source: `annual-reports/2014-15.pages.jsonl`\n- o its Environmental Management Policy to cover the activities, products and\nservices of its office-based operations at both the Canberra and Melbourne offices. The policy is based on\ninternational and domestic legislation, policies and standards, including:\n• Environmental Protection and Biodiversity Conservation Act 1999\n• AS/NZS ISO 14001:2004 – Environmental Management Systems\n• Australian Government Energy Efficiency in Government Operations (EEGO) Policy.\nNHMRC’s Environmental Management Policy enables us to incorporate environmental considerations such\nas energy and wate\n  Source: `annual-reports/2015-16.pages.jsonl`\n- t Policy\nNHMRC adheres to its Environmental Management Policy in the activities, products and services of\nits operations at its Canberra and Melbourne offices. The policy is based on international and domestic\nlegislation, policies and standards, including:\n• Environmental Protection and Biodiversity Conservation Act 1999\n• AS/NZS ISO 14001:2004 – Environmental Management Systems\n• Australian Government Energy Efficiency in Government Operations (EEGO) Policy.\nNHMRC incorporates environmental considerations such as energy and water conservation, waste and\nresource management i\n  Source: `annual-reports/2016-17.pages.jsonl`\n- e NHMRC Environmental Management Policy covers the activities, products and services\nof its office-based operations at both the Canberra and Melbourne offices. The policy is\nbased on international and domestic legislation, policies and standards, including:\n• Environmental Protection and Biodiversity Conservation Act 1999\n• AS/NZS ISO 14001:2004 – Environmental Management System\n• Australian Government Policy Framework for Greening of Government.\nThe policy enables NHMRC to incorporate environmental considerations such as energy and\nwater conservation, as well as waste and res\n  Source: `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n### Medical Research Future Fund Act 2015\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 5\n**Register search**: https://www.legislation.gov.au/search?query=Medical+Research+Future+Fund+Act+2015\n\n**Sources**:\n- `pages/structure.html`\n- `annual-reports/2016-17.pages.jsonl`\n- `corporate-plans/2017-18.pages.jsonl`\n- `corporate-plans/2024-25.pages.jsonl`\n- `corporate-plans/2025-26.pages.jsonl`\n\n**Evidence contexts**:\n- come an MRFF EO is managed by the grant hub administering the relevant MRFF funding – that is, NHMRC or the Business Grants Hub (BGH). This page outlines the process for obtaining EO status to apply for MRFF funding administered by NHMRC.\nThe objective of the\nMedical Research Future Fund Act 2015\nis to improve the health and wellbeing of Australians. The role of an MRFF EO is to support this objective by undertaking medical research and medical innovation activities in accordance with the terms and conditions set out in any MRFF Funding Agreement to w\n  Source: `pages/structure.html`\n- penditure on public health research and training, and\nmedical research and training.\nNHMRC also administers, and has statutory obligations under, the Prohibition of Human Cloning for\nReproduction Act 2002, the Research Involving Human Embryos Act 2002 and the Medical Research Future\nFund Act 2015.\n\n[page 91]\nAnnual Report of the National Health and Medical Research Council 2016–2017 81\ntnemnorivne\ngnitarepo\n3\nTRAP\nCorporate\ngovernance\nNHMRC’s robust corporate governance and compliance framework applies rigour and discipline to the way\nin which NHMRC d\n  Source: `annual-reports/2016-17.pages.jsonl`\n- ll over time provide substantial additional\nfunding for medical research and medical innovation. Strategic alignment between\nthe funding priorities of the MRFF and NHMRC is essential to ensure the efficient\nand effective allocation of funds from both sources. The Medical Research Future\nFund Act 2015 (MRFF Act) requires the MRFF’s Australian Medical Research Advisory\nBoard (AMRAB) to take into account NHMRC’s strategy for medical research and\npublic health research in determining the Australian Medical Research and Innovation\nStrategy. AMRAB has delivered\n  Source: `corporate-plans/2017-18.pages.jsonl`\n- on\nethical issues relating to health.\nNHMRC also administers and has legislated functions under the Research Involving Human\nEmbryos Act 2002 and the Prohibition of Human Cloning for Reproduction Act 2002. In\naddition, NHMRC exercises some functions under the Medical Research Future Fund Act\n2015.\nFigure 1: NHMRC’s mission and purposes\nBUILDING A HEALTHY AUSTRALIA\nINVESTMENT\nCreate knowledge and build research capability through\ninvestment in the highest-quality health and medical\nresearch and the best researchers.\nTRANSLATION\nDrive the translation of\n  Source: `corporate-plans/2024-25.pages.jsonl`\n- on ethical issues\nrelating to health.\nNHMRC also administers and has legislated functions under the Research Involving Human\nEmbryos Act 2002 and the Prohibition of Human Cloning for Reproduction Act 2002. In addition,\nNHMRC exercises some functions under the Medical Research Future Fund Act 2015.\nFigure 1: NHMRC’s mission and purposes\nBuilding a healthy Australia\nPURPOSES\nINVESTMENT\nCreate knowledge and build research capability through investment in\nthe highest-quality health and medical research and the best researchers.\nTRANSLATION\nDrive the trans\n  Source: `corporate-plans/2025-26.pages.jsonl`\n\n### PHCR Act) and the Research Involving Human Embryos Act 2002\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 5\n**Register search**: https://www.legislation.gov.au/search?query=PHCR+Act%29+and+the+Research+Involving+Human+Embryos+Act+2002\n\n**Sources**:\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `annual-reports/2015-16.pages.jsonl`\n- `annual-reports/2016-17.pages.jsonl`\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n**Evidence contexts**:\n- es for all involved in research.\n65\nAnnual Report of the National Health and Medical Research Council 2013–2014\n\n[page 74]\nPART 2 REPORT ON ACTIVITIES\nEMBRYO RESEARCH LICENSING COMMITTEE\nOF THE NHMRC\nThe Prohibition of Human Cloning for Reproduction Act 2002 (PHCR Act) and the Research Involving Human\nEmbryos Act 2002 (RIHE Act) regulate research activities that involve the use of human embryos created by\nassisted reproductive technology or other means. There are strong penalties for noncompliance. The Acts\nalso prohibit human cloning for reproductive purposes.\nThe NHMRC E\n  Source: `annual-reports/2013-14.pages.jsonl`\n- the National Health and Medical Research Council 2014–2015\n\n[page 80]\nPART 2 REPORT ON ACTIVITIES\nEMBRYO RESEARCH LICENSING COMMITTEE\nThe NHMRC Embryo Research Licensing Committee (ERLC) administers the Prohibition of Human Cloning\nfor Reproduction Act 2002 (PHCR Act) and the Research Involving Human Embryos Act 2002 (RIHE\nAct). These Acts regulate research activities that use human embryos created by assisted reproductive\ntechnology or other means. There are strong penalties for noncompliance. The Acts also prohibit human\ncloning for reproductive purposes.\nThe ERLC asses\n  Source: `annual-reports/2014-15.pages.jsonl`\n- elease of the guidelines on 11 April 2016.\nA full list of AHEC members is available at Appendix 4.\nEmbryo Research Licensing Committee\nThe NHMRC Embryo Research Licensing Committee (ERLC) administers the Prohibition of Human Cloning\nfor Reproduction Act 2002 (PHCR Act) and the Research Involving Human Embryos Act 2002 (RIHE Act).\nThese acts regulate research activities that use human embryos created by assisted reproductive technology\nor other means. There are strong penalties for noncompliance. The Acts also prohibit human cloning for\nreproductive purposes.\n90\n\n[page 99]\n  Source: `annual-reports/2015-16.pages.jsonl`\n- ctively, have membership of all the other\nPrincipal Committees.\nA list of AHEC members is in Appendix 3.\nEmbryo Research Licensing Committee\nThe Embryo Research Licensing Committee (ERLC) administers the Prohibition of Human Cloning for\nReproduction Act 2002 (PHCR Act) and the Research Involving Human Embryos Act 2002 (RIHE Act).\nThese Acts prohibit certain practices, including human cloning for reproduction. They also regulate use of\nexcess human embryos created through assisted reproductive technology, the creation of embryos by\nother means and use of such embryos for re\n  Source: `annual-reports/2016-17.pages.jsonl`\n- d the ninth Global Summit of National\nBioethics Advisory Bodies in Tunisia in September 2012. The next meeting will be held in\nJune in 2014 in Mexico.\nEmbryo Research Licensing Committee of the NHMRC\nThe Prohibition of Human Cloning for Reproduction Act 2002 (PHCR Act) and the Research\nInvolving Human Embryos Act 2002 (RIHE Act) prohibit human cloning for reproductive\npurposes and a range of other practices relating to reproductive technology. They also\nregulate research activities that involve the use of human embryos created by assisted\nreproductive technology or other m\n  Source: `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n### C.2 Commonwealth Electoral Act 1918\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 3\n**Register search**: https://www.legislation.gov.au/search?query=C.2+Commonwealth+Electoral+Act+1918\n\n**Sources**:\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n**Evidence contexts**:\n- l Statements\n13 Financial Statements Mandatory 98\nOther Mandatory Information\n14(1) & Work health and safety (Schedule 2, Part 4 of the Work Health Mandatory 87\nC.1 and Safety Act 2011)\n14(1) & Advertising and Market Research (Section 311A of the Mandatory 94\nC.2 Commonwealth Electoral Act 1918) and statement on\nadvertising campaigns\n14(1) & Ecologically sustainable development and environmental Mandatory 93\nC.3 performance (Section 516A of the Environment Protection and\nBiodiversity Conservation Act 1999)\n14(1) Compliance with the agency’s obligati\n  Source: `annual-reports/2013-14.pages.jsonl`\n- tements\n13 Financial Statements Mandatory 106-159\nOther Mandatory Information\n14(1) & Work health and safety (Schedule 2, Part 4 of the Work Health Mandatory 91\nC.1 and Safety Act 2011)\n14(1) & Advertising and Market Research (Section 311A of the Mandatory 99\nC.2 Commonwealth Electoral Act 1918) and statement on\nadvertising campaigns\n14(1) & Ecologically sustainable development and environmental Mandatory 97-98\nC.3 performance (Section 516A of the Environment Protection and\nBiodiversity Conservation Act 1999)\n14(1) Compliance with the agency’s oblig\n  Source: `annual-reports/2014-15.pages.jsonl`\n- Statements\n13 Financial Statements Mandatory 109\nOther Mandatory Information\n14(1) & Work health and safety (Schedule 2, Part 4 of the Work Mandatory 93\nC.1 Health and Safety Act 2011)\n14(1) & Advertising and Market Research (Section 311A of the Mandatory 102\nC.2 Commonwealth Electoral Act 1918) and statement on\nadvertising campaigns\n14(1) & Ecologically sustainable development and environmental Mandatory 101\nC.3 performance (Section 516A of the Environment\nProtection and Biodiversity Conservation Act 1999)\n14(1) Compliance with the agency’s obligat\n  Source: `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n### Commonwealth Electoral Act 1918\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 3\n**Register search**: https://www.legislation.gov.au/search?query=Commonwealth+Electoral+Act+1918\n\n**Sources**:\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n**Evidence contexts**:\n- tenancy rating. In November 2013 NHMRC achieved a 5.5 star NABERS\nEnergy tenancy rating.\n93\nAnnual Report of the National Health and Medical Research Council 2013–2014\n\n[page 102]\nPART 3 CORPORATE REPORTING\nADVERTISING AND MARKET RESEARCH\nSection 311A of the Commonwealth Electoral Act 1918 requires NHMRC to disclose in its annual report the\namount paid by or on behalf of NHMRC during the financial year to the following:\n• advertising agencies (meaning creative advertising agencies that have developed advertising campaigns)\n• polling organisatio\n  Source: `annual-reports/2013-14.pages.jsonl`\n- nancy rating.\n98\nAnnual Report of the National Health and Medical Research Council 2014–2015 Annual Report of the National Health and Medical Research Council 2014–2015\n\n[page 107]\nCORPORATE REPORTING PART 3\nADVERTISING AND MARKET RESEARCH\nSection 311A of the Commonwealth Electoral Act 1918 requires NHMRC to disclose in its annual report the\namount paid by or on behalf of NHMRC during the financial year to the following:\n• advertising agencies (meaning creative advertising agencies that have developed advertising campaigns)\n• polling organisatio\n  Source: `annual-reports/2014-15.pages.jsonl`\n- reporting, in accordance with the Energy Efficiency in Government Operations Policy.\nANNUAL REPORT OF THE NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL 2012–2013\n\n[page 108]\nPart three CORPORATE REPORTING\nADVERTISING AND MARKET RESEARCH\n102\nSection 311A of the Commonwealth Electoral Act 1918 requires NHMRC to disclose in\nits annual report the amount paid by or on behalf of NHMRC during the financial year to\nthe following:\n• advertising agencies (meaning creative advertising agencies that have developed\nadvertising campaigns)\n• polling organisatio\n  Source: `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n### Environment Protection and Biodiversity Conservation Act 1999\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 3\n**Register search**: https://www.legislation.gov.au/search?query=Environment+Protection+and+Biodiversity+Conservation+Act+1999\n\n**Sources**:\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n**Evidence contexts**:\n- 1) & Advertising and Market Research (Section 311A of the Mandatory 94\nC.2 Commonwealth Electoral Act 1918) and statement on\nadvertising campaigns\n14(1) & Ecologically sustainable development and environmental Mandatory 93\nC.3 performance (Section 516A of the Environment Protection and\nBiodiversity Conservation Act 1999)\n14(1) Compliance with the agency’s obligations under the Carer If applicable, N/A\nRecognition mandatory\nAct 2010\n14(2) & Grant programmes Mandatory 34\nD.1\n14(3) & Disability reporting – explicit and transparent reference to Mandatory 88\nD.2 agencylevel infor\n  Source: `annual-reports/2013-14.pages.jsonl`\n- & Advertising and Market Research (Section 311A of the Mandatory 99\nC.2 Commonwealth Electoral Act 1918) and statement on\nadvertising campaigns\n14(1) & Ecologically sustainable development and environmental Mandatory 97-98\nC.3 performance (Section 516A of the Environment Protection and\nBiodiversity Conservation Act 1999)\n14(1) Compliance with the agency’s obligations under the Carer If applicable, N/A\nRecognition mandatory\nAct 2010\n14(2) & Grant programmes Mandatory 34-72\nD.1\n14(3) & Disability reporting – explicit and transparent reference to Mandatory 91-92\nD.2 agencylevel\n  Source: `annual-reports/2014-15.pages.jsonl`\n- & Advertising and Market Research (Section 311A of the Mandatory 102\nC.2 Commonwealth Electoral Act 1918) and statement on\nadvertising campaigns\n14(1) & Ecologically sustainable development and environmental Mandatory 101\nC.3 performance (Section 516A of the Environment\nProtection and Biodiversity Conservation Act 1999)\n14(1) Compliance with the agency’s obligations under the Carer If applicable, N/A\nRecognition Act 2010 mandatory\n14(2) & Grant programs Mandatory 190\nD.1\n14(3) & Disability reporting – explicit and transparent reference to Mandatory 95\nD.2 agencylevel inform\n  Source: `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n### Portfolio Budget Statement PCHC Prevention and Community Health Committee PHCR Act Prohibition of Human Cloning for Reproduction Act 2002\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 3\n**Register search**: https://www.legislation.gov.au/search?query=Portfolio+Budget+Statement+PCHC+Prevention+and+Community+Health+Committee+PHCR+Act+Prohibition+of+Human+Cloning+for+Reproduction+Act+2002\n\n**Sources**:\n- `annual-reports/2013-14.pages.jsonl`\n- `annual-reports/2014-15.pages.jsonl`\n- `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n**Evidence contexts**:\n- ch Enabling Capabilities\nNHMRC National Health and Medical Research Council\nNIHR National Institute for Health Research\nNSFC National Natural Science Foundation of China\nOAIC Office of the Australian Information Commissioner\nOTA Organ and Tissue Authority\nPBS Portfolio Budget Statement\nPCHC Prevention and Community Health Committee\nPHCR Act Prohibition of Human Cloning for Reproduction Act 2002\nRGMS Research Grants Management System\nRIHE Act Research Involving Human Embryos Act 2002\nRMF Risk Management Framework\nRFA Request for Applications\nRTG Research Translation Group\nSES Senior Executive Service\nTRIP Translating Research into Practice\nTSANZ Tran\n  Source: `annual-reports/2013-14.pages.jsonl`\n- ndowment Account\nNHMRC National Health and Medical Research Council\nNIHR National Institute for Health Research\nNSFC National Natural Science Foundation of China\nOAIC Office of the Australian Information Commissioner\nORCID Open Research and Contributor ID\nPBS Portfolio Budget Statement\nPCHC Prevention and Community Health Committee\nPHCR Act Prohibition of Human Cloning for Reproduction Act 2002\nPGPA Public Governance, Performance and Accountability Act 2013\nRGMS Research Grants Management System\nRIHE Act Research Involving Human Embryos Act 2002\nRMF Risk Management Framework\nRFA Request for Applications\nSES Senior Executive Service\nTRIP Translating\n  Source: `annual-reports/2014-15.pages.jsonl`\n- Medical Research Endowment Account\nNAC NHMRC Audit Committee\nNHPA National Health Priority Area\nNHREC National Health Research Enabling Capabilities\nNHMRC National Health and Medical Research Council\nOAIC Office of the Australian Information Commissioner\nPBS Portfolio Budget Statement\nPCHC Prevention and Community Health Committee\nPHCR Act Prohibition of Human Cloning for Reproduction Act 2002\nRGMS Research Grants Management System\nRIHE Act Research Involving Human Embryos Act 2002\nRMF Risk Management Framework\nRTG Research Translation Group\nSES Senior Executive Service\nTRIP Translating Research into Practice\nWHS Work health and safety\nWQAC Water Q\n  Source: `other-pdfs/NationalHealthMedicalReasearchCouncil.pages.jsonl`\n\n### RGMS Research Grants Management System RIHE Act Research Involving Human Embryos Act 2002\n\n**Type**: Act\n**Confidence**: high\n**Mentions**: 3\n**Register search**: https://www.legislation.gov.au/search?query=RGMS+Research+Grants+Management+System+RI\n\n_…truncated, open the .md file for the full content._",
  "global_initiatives_md": null,
  "strategy": {
    "reporting_period": "2016-17",
    "corporate_plan_period": "2025-26",
    "vision": null,
    "vision_source_page": null,
    "purposes": "• fund high quality health and medical research and build research capability\n• support the translation of health and medical research into better health outcomes\n• promote the highest ethical standards in health and medical research",
    "purposes_source_page": [
      11
    ],
    "how_we_deliver": "NHMRC’s purposes are implemented through a strategy with three underpinning key themes: investment, translation and integrity. The corporate plan sets out the key activities and performance measures, along with specific targets for 2016–17, within each of these themes. These activities align with those identified in NHMRC’s Portfolio Budget Statements 2016–17 [CP p.11]",
    "how_we_deliver_source_page": null,
    "government_priorities": [],
    "outcomes": [
      {
        "name": "Outcome 1: Improved health and medical knowledge",
        "description": "NHMRC’s purposes are implemented through a strategy with three underpinning key themes: investment, translation and integrity. The corporate plan sets out the key activities and performance measures, along with specific targets for 2016–17, within each of these themes.",
        "key_activities": [
          "funding research",
          "translating research findings into evidence-based clinical practice",
          "administering legislation governing research",
          "issuing guidelines and advice for ethics in health and the promotion of public health"
        ],
        "source_page": [
          6
        ]
      }
    ],
    "values": [
      "Investment",
      "Translation",
      "Integrity"
    ],
    "values_framework_name": "NHMRC’s strategy for health and medical research",
    "kpi_targets_2025_26": [
      {
        "code": "CCE01",
        "measure": "Research grants are awarded, based on expert peer review, across the full spectrum of health and medical research areas.",
        "target": "Output",
        "source_page": [
          46
        ]
      },
      {
        "code": "CCE02",
        "measure": "More than 5% of NHMRC’s annual budget is awarded to research that aims to improve health outcomes for Aboriginal and Torres Strait Islander people.",
        "target": "Output",
        "source_page": [
          47
        ]
      },
      {
        "code": "CCE03",
        "measure": "Research integrity matters are managed appropriately by Administering Institutions in line with the requirements of the Australian Code for the Responsible Conduct of Research.",
        "target": "Effectiveness",
        "source_page": [
          49
        ]
      },
      {
        "code": "CCE04",
        "measure": "Compliance with regulatory requirements under the Research Involving Human Embryos Act 2002.",
        "target": "Effectiveness",
        "source_page": [
          49
        ]
      }
    ],
    "kpi_results_2024_25": [
      {
        "code": "CCE01",
        "measure": "Research grants are awarded, based on expert peer review, across the full spectrum of health and medical research areas.",
        "result": "Achieved",
        "status": "Achieved",
        "source_page": [
          31
        ]
      },
      {
        "code": "CCE02",
        "measure": "More than 5% of NHMRC’s annual budget is awarded to research that aims to improve health outcomes for Aboriginal and Torres Strait Islander people.",
        "result": "Achieved",
        "status": "Achieved",
        "source_page": [
          31
        ]
      },
      {
        "code": "CCE03",
        "measure": "Research integrity matters are managed appropriately by Administering Institutions in line with the requirements of the Australian Code for the Responsible Conduct of Research.",
        "result": "Work ongoing",
        "status": "Work ongoing",
        "source_page": [
          35
        ]
      },
      {
        "code": "CCE04",
        "measure": "Compliance with regulatory requirements under the Research Involving Human Embryos Act 2002.",
        "result": "Work ongoing",
        "status": "Work ongoing",
        "source_page": [
          35
        ]
      }
    ],
    "_source_urls": {
      "annual_report_url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf",
      "corporate_plan_url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf"
    }
  },
  "ideas": [
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Data & Performance",
      "scale": "small",
      "title": "KPI evidence register with named owners",
      "idea": "Create a simple register mapping each KPI to source data, owner, frequency, target, and last result.",
      "quote": "Goal 7: Promote access to and use of ‘big data’ to improve health\nTarget 1 Collaborate with relevant Australian and international groups regarding the use of ‘big data’ work ongoing\nTarget 2 Continue to encourage data-sharing practices to maximise the benefits derived from NHMrC- work ongoing\nfunded research\nTarget 3 refine guidance for researchers to consider data and metadata management in their research work ongoing\nTarget 4 release NHMrC’s Principles for Accessing and Using Publicly Funded Data for Health Research Achieved\nOutcome 7: N HMRC has continued to work with national and international agencies to promote\nthe use and sharing of data.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / Parliament / public",
      "source": "annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    },
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Data & Performance",
      "scale": "large",
      "title": "Outcome dashboard linking budget, delivery, and public impact",
      "idea": "Build a public-facing outcome dashboard showing spend, outputs, outcomes, and delivery confidence.",
      "quote": "Goal 7: Promote access to and use of ‘big data’ to improve health\nTarget 1 Collaborate with relevant Australian and international groups regarding the use of ‘big data’ work ongoing\nTarget 2 Continue to encourage data-sharing practices to maximise the benefits derived from NHMrC- work ongoing\nfunded research\nTarget 3 refine guidance for researchers to consider data and metadata management in their research work ongoing\nTarget 4 release NHMrC’s Principles for Accessing and Using Publicly Funded Data for Health Research Achieved\nOutcome 7: N HMRC has continued to work with national and international agencies to promote\nthe use and sharing of data.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / Parliament / public",
      "source": "annual-reports/2015-16.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    },
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Risk & Assurance",
      "scale": "small",
      "title": "Recommendation tracker for audits, reviews, and inquiries",
      "idea": "Publish a single internal tracker for audit/review recommendations, owners, due dates, and implementation evidence.",
      "quote": "Strategic risks Operational risks\n26 Corporate Plan 2024–25 National Health and Medical Research Council\nytilibapaC\nRisk description Risk tolerance Primary control/s\nBuilding innovative Moderate Maintain an appropriate\ninformation and governance structure to oversee\ncommunications project management and budgets,\ntechnology (ICT) including regular review of risks\nto support business and issues.\ncapability exceeds\nDesign and test ICT solutions with\ntime, solutions\ninternal and external users and\noperate suboptimally\nimplement enhancements over\nor increase\ntime, as feasible and where most\nthe burden on\nneeded.\nstakeholders.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / assurance teams",
      "source": "corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    },
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Risk & Assurance",
      "scale": "large",
      "title": "Integrated assurance and lessons-learned system",
      "idea": "Create an assurance system that connects audit findings, risk registers, delivery reviews, and investment decisions.",
      "quote": "Strategic risks Operational risks\n26 Corporate Plan 2024–25 National Health and Medical Research Council\nytilibapaC\nRisk description Risk tolerance Primary control/s\nBuilding innovative Moderate Maintain an appropriate\ninformation and governance structure to oversee\ncommunications project management and budgets,\ntechnology (ICT) including regular review of risks\nto support business and issues.\ncapability exceeds\nDesign and test ICT solutions with\ntime, solutions\ninternal and external users and\noperate suboptimally\nimplement enhancements over\nor increase\ntime, as feasible and where most\nthe burden on\nneeded.\nstakeholders.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Executives / assurance teams",
      "source": "corporate-plans/2024-25.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    },
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Staff Productivity",
      "scale": "small",
      "title": "Reusable briefing and summary assistant for internal documents",
      "idea": "Create controlled templates for summarising reports, submissions, minutes, and ministerial briefs.",
      "quote": "Table 2 Portfolio Budget Statement – NHMRC expenses and resources\nOutcome 1: Improved health and medical knowledge,\nincluding through funding research, translating Actual\nresearch findings into evidence-based clinical Budget* Expenses Variation\npractice, administering legislation governing research, 2014-15 2014-15 2014-15\nissuing guidelines and advice for ethics in health and $’000 $’000 $’000\nthe promotion of public health. (a) (b) (a)-(b)\nProgramme 1.1: Health and Medical Research\nAdministered expenses\nOrdinary Annual Services (Appropriation Act No.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "APS staff / executives",
      "source": "annual-reports/2014-15.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Sensitive information leakage",
        "Inconsistent quality of generated drafts"
      ]
    },
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Staff Productivity",
      "scale": "large",
      "title": "Department-wide knowledge and briefing platform",
      "idea": "Build a secure knowledge platform that lets staff search, summarise, and cite approved departmental material.",
      "quote": "Table 2 Portfolio Budget Statement – NHMRC expenses and resources\nOutcome 1: Improved health and medical knowledge,\nincluding through funding research, translating Actual\nresearch findings into evidence-based clinical Budget* Expenses Variation\npractice, administering legislation governing research, 2014-15 2014-15 2014-15\nissuing guidelines and advice for ethics in health and $’000 $’000 $’000\nthe promotion of public health. (a) (b) (a)-(b)\nProgramme 1.1: Health and Medical Research\nAdministered expenses\nOrdinary Annual Services (Appropriation Act No.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "APS staff / executives",
      "source": "annual-reports/2014-15.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Sensitive information leakage",
        "Inconsistent quality of generated drafts"
      ]
    },
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Case Processing",
      "scale": "small",
      "title": "Triage queue for stuck or ageing cases",
      "idea": "Use existing case data to flag ageing, duplicate, incomplete, or high-risk cases for earlier intervention.",
      "quote": "Target Methodology Measure type Reporting years\n3 Better matching of peer Analysis of the peer review Efficiency and 2025–26\nreviewers to applications, process, including level of self- effectiveness 2026–27\nimproving application- reported suitability matching of\n2027–28\ncentric peer review in peer reviewers to applications,\napplicable schemes, and feedback from reviewers and 2028–29\nreduced burden on peer measurement of time spent on\nreviewers. peer review.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Applicants / case officers",
      "source": "corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    },
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Case Processing",
      "scale": "large",
      "title": "End-to-end case processing redesign",
      "idea": "Redesign the case pathway around risk-based triage, reusable evidence, and automated eligibility checks.",
      "quote": "Target Methodology Measure type Reporting years\n3 Better matching of peer Analysis of the peer review Efficiency and 2025–26\nreviewers to applications, process, including level of self- effectiveness 2026–27\nimproving application- reported suitability matching of\n2027–28\ncentric peer review in peer reviewers to applications,\napplicable schemes, and feedback from reviewers and 2028–29\nreduced burden on peer measurement of time spent on\nreviewers. peer review.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Applicants / case officers",
      "source": "corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    },
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Procurement & Delivery",
      "scale": "small",
      "title": "Procurement lessons library for repeat purchases",
      "idea": "Capture reusable procurement clauses, market lessons, supplier performance notes, and common evaluation criteria.",
      "quote": "Table 1 Investigator Initiated and Priority Driven NHMRC Funding\nOutcomes in 20157\nMAIN 2015\nFUNDING GRANT TYPE[a] GRANT SUB-TYPE\nINVESTIGATOR PRIORITY\nGROUP\nNew Investigator Grant $14,996,978\nStandard Project Grant $383,431,356\nProject Grants\nAboriginal and Torres Strait Islander\n$21,246,639\nHealth Research\nProgram Grants Program Grant $108,742,325\nCentre of Research Excellence\n$12,149,997\n– Clinical\nCentres of Research Centre of Research Excellence\n$12,198,638\nExcellence – Health Services\nCentre of Research Excellence\n$12,478,085\n– Population Health\nDevelopment Grants Development Grant $14,142,312\nPartnership Projects Partnership Project for Better Health $18,436,290\nAust/EU Collaborative Research\n$5,495,919\nGrant\nCalifornia Institute for Regenerative\nResearch Medicine (CIRM) – Tools and $1,784,170\nSupport Technologies Stem Cells Research\nInternational",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Delivery teams / suppliers",
      "source": "corporate-plans/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/2d6f9cb6-500b-4651-a2ad-d7785ebffe53/upload_pdf/16390_nhmrc_-_nhmrc_corporate_plan_2016-17_0.pdf;fileType=application%2Fpdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    },
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Procurement & Delivery",
      "scale": "large",
      "title": "Portfolio delivery office for major investments",
      "idea": "Stand up a portfolio delivery office that tracks benefits, risks, dependencies, procurement, and delivery confidence.",
      "quote": "Table 1 Investigator Initiated and Priority Driven NHMRC Funding\nOutcomes in 20157\nMAIN 2015\nFUNDING GRANT TYPE[a] GRANT SUB-TYPE\nINVESTIGATOR PRIORITY\nGROUP\nNew Investigator Grant $14,996,978\nStandard Project Grant $383,431,356\nProject Grants\nAboriginal and Torres Strait Islander\n$21,246,639\nHealth Research\nProgram Grants Program Grant $108,742,325\nCentre of Research Excellence\n$12,149,997\n– Clinical\nCentres of Research Centre of Research Excellence\n$12,198,638\nExcellence – Health Services\nCentre of Research Excellence\n$12,478,085\n– Population Health\nDevelopment Grants Development Grant $14,142,312\nPartnership Projects Partnership Project for Better Health $18,436,290\nAust/EU Collaborative Research\n$5,495,919\nGrant\nCalifornia Institute for Regenerative\nResearch Medicine (CIRM) – Tools and $1,784,170\nSupport Technologies Stem Cells Research\nInternational",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Delivery teams / suppliers",
      "source": "corporate-plans/2016-17.pdf (https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/2d6f9cb6-500b-4651-a2ad-d7785ebffe53/upload_pdf/16390_nhmrc_-_nhmrc_corporate_plan_2016-17_0.pdf;fileType=application%2Fpdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability"
      ]
    },
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Regulation & Policy",
      "scale": "small",
      "title": "Regulatory burden scan for forms, guidance, and reporting",
      "idea": "Identify the top 10 highest-friction reporting obligations and simplify guidance, forms, or evidence requirements.",
      "quote": "Target Methodology Measure type Reporting years\n12 Compliance with Qualitative assessment from Effectiveness 2025–26\nregulatory requirements inspections and six-monthly reports 2026–27\nunder the Research is used to calculate the number and\n2027–28\nInvolving Human type of incidents of non-compliance\nEmbryos Act 2002. with licence conditions by each licence 2028–29\nholder in the period, as well as how\nquickly and effectively any actions to\nredress non-compliance (as required\nby the regulator) are actioned by the\nlicence holder.",
      "impact": "High",
      "effort": "Low",
      "proof": "Evidence-backed",
      "beneficiaries": "Regulated entities / policy teams",
      "source": "corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)",
      "implementation": [
        "Pick one high-volume process or document family.",
        "Name an owner and baseline current volume, time, cost, and satisfaction.",
        "Run a 4-8 week pilot with clear before/after metrics.",
        "Publish lessons and decide whether to scale."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    },
    {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "category": "Regulation & Policy",
      "scale": "large",
      "title": "Adaptive regulation program with live feedback loops",
      "idea": "Create an adaptive regulation model using sandboxes, industry data, risk scoring, and regular rule updates.",
      "quote": "Target Methodology Measure type Reporting years\n12 Compliance with Qualitative assessment from Effectiveness 2025–26\nregulatory requirements inspections and six-monthly reports 2026–27\nunder the Research is used to calculate the number and\n2027–28\nInvolving Human type of incidents of non-compliance\nEmbryos Act 2002. with licence conditions by each licence 2028–29\nholder in the period, as well as how\nquickly and effectively any actions to\nredress non-compliance (as required\nby the regulator) are actioned by the\nlicence holder.",
      "impact": "Very High",
      "effort": "High",
      "proof": "Evidence-backed",
      "beneficiaries": "Regulated entities / policy teams",
      "source": "corporate-plans/2025-26.pdf (https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf)",
      "implementation": [
        "Create a senior responsible owner and cross-functional delivery team.",
        "Map legislation, data, privacy, procurement, cyber, and workforce constraints.",
        "Co-design with users and frontline staff before technology selection.",
        "Stage delivery through pilots, benefits tracking, and public reporting."
      ],
      "risks": [
        "Privacy and data quality",
        "Change fatigue",
        "Unclear accountability",
        "Regulatory capture",
        "Over-automation of judgement"
      ]
    }
  ],
  "legislation_administered": [],
  "artifacts": [
    {
      "category": "annual-reports",
      "year": "2016-17",
      "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf",
      "file": "annual-reports/2016-17.pdf",
      "bytes": 5640749,
      "link_text": "2016–17"
    },
    {
      "category": "annual-reports",
      "year": "2015-16",
      "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/ed0e0bfe-feb1-40bb-ba07-01cfa956533c/upload_pdf/16243_nhmrc_annual_report_2015-16_web_2.pdf;fileType=application%2Fpdf",
      "file": "annual-reports/2015-16.pdf",
      "bytes": 3717899,
      "link_text": "2015–16"
    },
    {
      "category": "annual-reports",
      "year": "2014-15",
      "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/a2dc2a8f-9967-4f76-b5b9-35c71c622ebd/upload_pdf/nh169_nhmrc_annual_report_2014_15_web.pdf",
      "file": "annual-reports/2014-15.pdf",
      "bytes": 3357215,
      "link_text": "2014–15"
    },
    {
      "category": "annual-reports",
      "year": "2013-14",
      "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/baa4d524-2b51-4ae9-8ae2-8667b250661d/upload_pdf/nh166_nhmrc_annual_report_2013_2014_accessible.pdf",
      "file": "annual-reports/2013-14.pdf",
      "bytes": 2458424,
      "link_text": "2013–14"
    },
    {
      "category": "corporate-plans",
      "year": "2025-26",
      "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
      "file": "corporate-plans/2025-26.pdf",
      "bytes": 8185819,
      "link_text": "NHMRC Corporate Plan 2025–26"
    },
    {
      "category": "corporate-plans",
      "year": "2024-25",
      "url": "https://www.nhmrc.gov.au/sites/default/files/documents/reports/Annual%20reports/Corporate-Plan-2024-25.pdf",
      "file": "corporate-plans/2024-25.pdf",
      "bytes": 3133387,
      "link_text": "NHMRC Corporate Plan 2024–25"
    },
    {
      "category": "corporate-plans",
      "year": "2018-19",
      "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/77446457-0aed-405b-b234-73321c169df2/upload_pdf/corporate-plan-2018-2019.pdf;fileType=application%2Fpdf",
      "file": "corporate-plans/2018-19.pdf",
      "bytes": 1590102,
      "link_text": "2018–19"
    },
    {
      "category": "corporate-plans",
      "year": "2017-18",
      "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/4ba2e828-a6a9-4c84-beab-a45c39967b6e/upload_pdf/17293_nhmrc_corporate_plan_2017-18-web.pdf;fileType=application%2Fpdf",
      "file": "corporate-plans/2017-18.pdf",
      "bytes": 1529952,
      "link_text": "2017–18"
    },
    {
      "category": "corporate-plans",
      "year": "2016-17",
      "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/2d6f9cb6-500b-4651-a2ad-d7785ebffe53/upload_pdf/16390_nhmrc_-_nhmrc_corporate_plan_2016-17_0.pdf;fileType=application%2Fpdf",
      "file": "corporate-plans/2016-17.pdf",
      "bytes": 1565711,
      "link_text": "2016–17"
    },
    {
      "category": "strategies",
      "year": "2023",
      "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/international/International-Engagement-Strategy-2023-2026.pdf",
      "file": "strategies/International-Engagement-Strategy-2023-2026.pdf",
      "bytes": 247028,
      "link_text": "International Engagement Strategy 2023–2026"
    },
    {
      "category": "strategies",
      "year": null,
      "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/NHMRC_Gender_Equity_Strategy_FA.pdf",
      "file": "strategies/NHMRC_Gender_Equity_Strategy_FA.pdf",
      "bytes": 112699,
      "link_text": "NHMRC Gender Equity Strategy"
    },
    {
      "category": "strategies",
      "year": null,
      "url": "https://www.canceraustralia.gov.au/sites/default/files/migrated-files/publications/national_consumer_framework_web_504af020f2184.pdf",
      "file": "strategies/national_consumer_framework_web_504af020f2184.pdf",
      "bytes": 2621196,
      "link_text": "National Framework for Consumer Involvement in Cancer Control | Cancer Australia"
    },
    {
      "category": "reviews",
      "year": null,
      "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/final-report-national-scientific-committees.pdf",
      "file": "reviews/final-report-national-scientific-committees.pdf",
      "bytes": 1962346,
      "link_text": "Report from the pilot – National Scientific Committee"
    },
    {
      "category": "other-pdfs",
      "year": "2010",
      "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/HSTP014428_2010-13/upload_pdf/14428_2010-13.pdf",
      "file": "other-pdfs/14428_2010-13.pdf",
      "bytes": 8240335,
      "link_text": "2013–2015"
    },
    {
      "category": "other-pdfs",
      "year": "2008",
      "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/HSTP018845_2008-10/upload_pdf/18845_2008-10.pdf",
      "file": "other-pdfs/18845_2008-10.pdf",
      "bytes": 5267520,
      "link_text": "2010–2012"
    },
    {
      "category": "other-pdfs",
      "year": "2012-13",
      "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/70716/upload_pdf/NationalHealthMedicalReasearchCouncil.pdf",
      "file": "other-pdfs/NationalHealthMedicalReasearchCouncil.pdf",
      "bytes": 1890914,
      "link_text": "2012–13"
    }
  ],
  "_meta": {
    "snapshot_built_at": "2026-05-13T11:02:56+00:00",
    "strategy_brief_meta": {
      "model": "nova-micro",
      "folder": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "annual_report": {
        "file": "annual-reports\\2016-17.txt",
        "url": "https://parlinfo.aph.gov.au/parlInfo/download/publications/tabledpapers/b1265726-e6c9-42a4-b2e1-cdef3ce84e68/upload_pdf/nhmrc_annualreport2016-2017.pdf;fileType=application%2Fpdf",
        "year": "2016-17"
      },
      "corporate_plan": {
        "file": "corporate-plans\\2025-26.txt",
        "url": "https://www.nhmrc.gov.au/sites/default/files/documents/attachments/publications/Corporate-Plan-2025-26.pdf",
        "year": "2025-26"
      },
      "usage": {
        "input_tokens": 36281,
        "output_tokens": 978,
        "total_tokens": 37259,
        "model": "nova-micro"
      },
      "cost_usd": 0.0014067550000000002,
      "elapsed_seconds": 31.0,
      "generated_at": "2026-05-13T04:17:51+00:00"
    },
    "ideas_manifest": {
      "entity_id": "B-001937",
      "entity_name": "National Health and Medical Research Council - Embryo Research and Licensing Committee",
      "folder_name": "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee",
      "generated_at": "2026-05-09T23:05:41.015949+00:00",
      "idea_count": 12,
      "markdown": "ideas/National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee_ideas.md",
      "jsonl": "ideas/ideas.jsonl",
      "inputs": [
        "National-Health-and-Medical-Research-Council-Embryo-Research-and-Licensing-Committee_strategy-overview.md",
        "strategy-evidence.json",
        "global-intelligence/source-manifest.json"
      ]
    },
    "global_intel_meta": null
  }
}